<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:03:23Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9319619" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9319619</identifier>
        <datestamp>2022-07-27</datestamp>
        <setSpec>genes</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Genes (Basel)</journal-id>
              <journal-id journal-id-type="iso-abbrev">Genes (Basel)</journal-id>
              <journal-id journal-id-type="publisher-id">genes</journal-id>
              <journal-title-group>
                <journal-title>Genes</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2073-4425</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9319619</article-id>
              <article-id pub-id-type="pmcid">PMC9319619</article-id>
              <article-id pub-id-type="pmc-uid">9319619</article-id>
              <article-id pub-id-type="pmid">35886043</article-id>
              <article-id pub-id-type="doi">10.3390/genes13071260</article-id>
              <article-id pub-id-type="publisher-id">genes-13-01260</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Armstrong</surname>
                    <given-names>Nicole D.</given-names>
                  </name>
                  <xref rid="af1-genes-13-01260" ref-type="aff">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Srinivasasainagendra</surname>
                    <given-names>Vinodh</given-names>
                  </name>
                  <xref rid="af2-genes-13-01260" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chekka</surname>
                    <given-names>Lakshmi Manasa S.</given-names>
                  </name>
                  <xref rid="af3-genes-13-01260" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3036-4748</contrib-id>
                  <name>
                    <surname>Nguyen</surname>
                    <given-names>Nam H. K.</given-names>
                  </name>
                  <xref rid="af4-genes-13-01260" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nahid</surname>
                    <given-names>Noor A.</given-names>
                  </name>
                  <xref rid="af4-genes-13-01260" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jones</surname>
                    <given-names>Alana C.</given-names>
                  </name>
                  <xref rid="af1-genes-13-01260" ref-type="aff">1</xref>
                  <xref rid="af5-genes-13-01260" ref-type="aff">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tanner</surname>
                    <given-names>Rikki M.</given-names>
                  </name>
                  <xref rid="af1-genes-13-01260" ref-type="aff">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hidalgo</surname>
                    <given-names>Bertha A.</given-names>
                  </name>
                  <xref rid="af1-genes-13-01260" ref-type="aff">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Limdi</surname>
                    <given-names>Nita A.</given-names>
                  </name>
                  <xref rid="af6-genes-13-01260" ref-type="aff">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9789-8395</contrib-id>
                  <name>
                    <surname>Claas</surname>
                    <given-names>Steven A.</given-names>
                  </name>
                  <xref rid="af7-genes-13-01260" ref-type="aff">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gong</surname>
                    <given-names>Yan</given-names>
                  </name>
                  <xref rid="af4-genes-13-01260" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McDonough</surname>
                    <given-names>Caitrin W.</given-names>
                  </name>
                  <xref rid="af4-genes-13-01260" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5198-130X</contrib-id>
                  <name>
                    <surname>Cooper-DeHoff</surname>
                    <given-names>Rhonda M.</given-names>
                  </name>
                  <xref rid="af4-genes-13-01260" ref-type="aff">4</xref>
                  <xref rid="af8-genes-13-01260" ref-type="aff">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Johnson</surname>
                    <given-names>Julie A.</given-names>
                  </name>
                  <xref rid="af4-genes-13-01260" ref-type="aff">4</xref>
                  <xref rid="af8-genes-13-01260" ref-type="aff">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tiwari</surname>
                    <given-names>Hemant K.</given-names>
                  </name>
                  <xref rid="af2-genes-13-01260" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Arnett</surname>
                    <given-names>Donna K.</given-names>
                  </name>
                  <xref rid="af7-genes-13-01260" ref-type="aff">7</xref>
                  <xref rid="af9-genes-13-01260" ref-type="aff">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Irvin</surname>
                    <given-names>Marguerite R.</given-names>
                  </name>
                  <xref rid="af1-genes-13-01260" ref-type="aff">1</xref>
                  <xref rid="c1-genes-13-01260" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Machado</surname>
                    <given-names>Rajiv</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <aff id="af1-genes-13-01260"><label>1</label>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; <email>nmda@uab.edu</email> (N.D.A.); <email>acjones@uab.edu</email> (A.C.J.); <email>rmdeitz@uab.edu</email> (R.M.T.); <email>bhidalgo@uab.edu</email> (B.A.H.)</aff>
              <aff id="af2-genes-13-01260"><label>2</label>Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294, USA; <email>vinodh@uab.edu</email> (V.S.); <email>htiwari@uab.edu</email> (H.K.T.)</aff>
              <aff id="af3-genes-13-01260"><label>3</label>Division of Applied Regulatory Sciences, Center for Drug Evaluation and Research, Silver Spring, MD 20903, USA; <email>lakshmimanasa.chekka@fda.hhs.gov</email></aff>
              <aff id="af4-genes-13-01260"><label>4</label>Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA; <email>namnguyen@ufl.edu</email> (N.H.K.N.); <email>n.nahid@ufl.edu</email> (N.A.N.); <email>gong@cop.ufl.edu</email> (Y.G.); <email>cmcdonough@cop.ufl.edu</email> (C.W.M.); <email>dehoff@cop.ufl.edu</email> (R.M.C.-D.); <email>julie.johnson@ufl.edu</email> (J.A.J.)</aff>
              <aff id="af5-genes-13-01260"><label>5</label>Medical Scientist Training Program, University of Alabama at Birmingham, Birmingham, AL 35294, USA</aff>
              <aff id="af6-genes-13-01260"><label>6</label>Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; <email>nlimdi@uabmc.edu</email></aff>
              <aff id="af7-genes-13-01260"><label>7</label>Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY 40506, USA; <email>steven.claas@uky.edu</email> (S.A.C.); <email>donna.arnett@uky.edu</email> (D.K.A.)</aff>
              <aff id="af8-genes-13-01260"><label>8</label>Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL 32611, USA</aff>
              <aff id="af9-genes-13-01260"><label>9</label>Deans Office, College of Public Health, University of Kentucky, Lexington, KY 40506, USA</aff>
              <author-notes>
                <corresp id="c1-genes-13-01260"><label>*</label>Correspondence: <email>irvinr@uab.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>15</day>
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <volume>13</volume>
              <issue>7</issue>
              <elocation-id>1260</elocation-id>
              <history>
                <date date-type="received">
                  <day>07</day>
                  <month>6</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>07</day>
                  <month>7</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2022 by the authors.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Hypertension is a leading risk factor for cardiovascular disease mortality. African Americans (AAs) have the highest prevalence of hypertension in the United States, and to alleviate the burden of hypertension in this population, better control of blood pressure (BP) is needed. Previous studies have shown considerable interpersonal differences in BP response to antihypertensive treatment, suggesting a genetic component. Utilizing data from 4297 AA participants randomized to chlorthalidone from the Genetics of Hypertension Associated Treatments (GenHAT) study, we aimed to identify variants associated with the efficacy of chlorthalidone. An additional aim was to find variants that contributed to changes in fasting glucose (FG) in these individuals. We performed genome-wide association analyses on the change of systolic and diastolic BP (SBP and DBP) over six months and FG levels over 24 months of treatment. We sought replication in the International Consortia of Pharmacogenomics Studies. We identified eight variants statistically associated with BP response and nine variants associated with FG response. One suggestive <italic toggle="yes">LINC02211-CDH9</italic> intergenic variant was marginally replicated with the same direction of effect. Given the impact of hypertension in AAs, this study implies that understanding the genetic background for BP control and glucose changes during chlorthalidone treatment may help prevent adverse cardiovascular events in this population.</p>
              </abstract>
              <kwd-group>
                <kwd>pharmacogenomics</kwd>
                <kwd>antihypertensives</kwd>
                <kwd>drug response</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)</funding-source>
                  <award-id>R01HL123782 (MRI)</award-id>
                </award-group>
                <award-group>
                  <funding-source>NIH NHLBI training grant</funding-source>
                  <award-id>T32HL007457</award-id>
                </award-group>
                <award-group>
                  <funding-source>NIH National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) F31 Fellowship</funding-source>
                  <award-id>F31DK128990</award-id>
                </award-group>
                <award-group>
                  <funding-source>NIH NHLBI</funding-source>
                  <award-id>K01HL141690</award-id>
                </award-group>
                <funding-statement>This research was funded by National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) grant R01HL123782 (MRI). N.D.A. was supported by an NIH NHLBI training grant, T32HL007457. A.C.J. was supported by an NIH National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) F31 Fellowship, F31DK128990. C.W.M. was supported by NIH NHLBI K01HL141690.</funding-statement>
              </funding-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1-genes-13-01260">
              <title>1. Introduction</title>
              <p>Hypertension (HTN) is a leading risk factor contributing to cardiovascular diseases (CVD) worldwide, attributing to ~10.7 million deaths annually [<xref rid="B1-genes-13-01260" ref-type="bibr">1</xref>]. Effective blood pressure (BP) control is critical for the reduction of CVD, as demonstrated in the Systolic Blood Pressure Intervention Trial (SPRINT), where aggressively targeting lower systolic BP (SBP) with antihypertensive treatment (&lt;120 mmHg) versus the standard treatment (&lt;140 mmHg) reduced the risk of myocardial infarction, acute coronary syndromes, stroke, heart failure, or CVD death by 27% [<xref rid="B2-genes-13-01260" ref-type="bibr">2</xref>]. BP control is especially important for African Americans (AA), who have an earlier onset and higher prevalence of HTN compared to individuals of European ancestry (EA) [<xref rid="B3-genes-13-01260" ref-type="bibr">3</xref>,<xref rid="B4-genes-13-01260" ref-type="bibr">4</xref>]. A higher prevalence of HTN is paired with poorer BP control in AAs which cannot be attributed to differences in awareness and treatment or dietary factors [<xref rid="B5-genes-13-01260" ref-type="bibr">5</xref>,<xref rid="B6-genes-13-01260" ref-type="bibr">6</xref>]. </p>
              <p>Previous studies have shown that interindividual and racial differences in BP response to first-line antihypertensive treatments exist [<xref rid="B7-genes-13-01260" ref-type="bibr">7</xref>,<xref rid="B8-genes-13-01260" ref-type="bibr">8</xref>], with ~50% of patients achieving adequate BP response to anyone antihypertensive therapy [<xref rid="B9-genes-13-01260" ref-type="bibr">9</xref>]. Compared to EAs, AA patients have poorer BP lowering response to β-blockers, angiotensin converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers and exhibit a better response to calcium channel blockers (CCB) or thiazide diuretics (TD), when used as monotherapy, thus making CCB or TD the suggested first-line antihypertensive therapy for AAs [<xref rid="B7-genes-13-01260" ref-type="bibr">7</xref>]. While observational studies and randomized trials of BP response have highlighted several metabolic disturbances, hyperglycemia is of great concern [<xref rid="B10-genes-13-01260" ref-type="bibr">10</xref>,<xref rid="B11-genes-13-01260" ref-type="bibr">11</xref>]. In the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT), chlorthalidone use increased fasting glucose (FG) by 8.5 mg/dL on average versus an average increase of 5.5 mg/dL in the amlodipine (CCB) group or 3.5 mg/dL for the lisinopril group (ACEI) [<xref rid="B12-genes-13-01260" ref-type="bibr">12</xref>]. This is of importance, particularly in AAs, who have a longer duration of antihypertensive use due to earlier onset HTN, as well as a higher risk of type 2 diabetes (T2D). </p>
              <p>Interindividual BP response to antihypertensives is highly variable at the population level, alluding to a possible genetic component to the antihypertensive response. Genetic studies of BP response to antihypertensive treatment and BP control on antihypertensive treatment are especially vulnerable to medication adherence, as well as noise due to treatment with multiple drugs. Compared to purely observational research of hypertension-related phenotypes, studies set within a clinical trial can minimize many of these limiting factors because participants are randomized to monotherapy first with careful follow-up for BP control and treatment titration as needed using predefined algorithms. Clinical trials also allow evaluation of BP response as a quantitative trait upon new drug exposure (i.e., change in BP from baseline to follow-up), an outcome that is usually not possible to consider using observational data. From a public health standpoint, there is increasing recognition of the need for precision medicine by clinicians, health systems, patients, and policymakers, yet research lags behind this growing demand. Unfortunately, there have been a limited number of pharmacogenetic studies of antihypertensive treatment responses and AAs have been underrepresented in those studies [<xref rid="B13-genes-13-01260" ref-type="bibr">13</xref>]. Candidate gene and genome-wide association studies (GWAS) have uncovered suggestive loci, but a large GWAS of treatment response has not been undertaken in AAs [<xref rid="B14-genes-13-01260" ref-type="bibr">14</xref>,<xref rid="B15-genes-13-01260" ref-type="bibr">15</xref>,<xref rid="B16-genes-13-01260" ref-type="bibr">16</xref>,<xref rid="B17-genes-13-01260" ref-type="bibr">17</xref>,<xref rid="B18-genes-13-01260" ref-type="bibr">18</xref>,<xref rid="B19-genes-13-01260" ref-type="bibr">19</xref>,<xref rid="B20-genes-13-01260" ref-type="bibr">20</xref>,<xref rid="B21-genes-13-01260" ref-type="bibr">21</xref>,<xref rid="B22-genes-13-01260" ref-type="bibr">22</xref>]. Utilizing data from the Genetics of Hypertension Associated Treatments (GenHAT), we aimed to identify genetic variation in the antihypertensive efficacy of chlorthalidone over a six-month period for 4297 AA participants, as well as any genetic risk attributing to changes in FG levels.</p>
            </sec>
            <sec id="sec2-genes-13-01260">
              <title>2. Materials and Methods</title>
              <sec id="sec2dot1-genes-13-01260">
                <title>2.1. Study Population</title>
                <p>The GenHAT study is an ancillary pharmacogenomics study to the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT was a randomized, double-blind, multi-center trial that enrolled 42,418 participants ≥55 years of age with HTN and at least one additional risk factor for CVD [<xref rid="B23-genes-13-01260" ref-type="bibr">23</xref>]. Participants were randomized to treatment with one of four primary antihypertensive drugs: chlorthalidone (thiazide-like diuretic), amlodipine (CCB), lisinopril (ACEI), or doxazosin (α-adrenergic blocker) in a ratio of 1.7:1:1:1, respectively [<xref rid="B23-genes-13-01260" ref-type="bibr">23</xref>]. The original GenHAT study (<italic toggle="yes">n</italic> = 39,114) evaluated the interaction between candidate hypertensive genetic variants and different antihypertensive treatments to modify the risk of fatal and non-fatal CVD outcomes [<xref rid="B24-genes-13-01260" ref-type="bibr">24</xref>]. The current study focuses on 7593 GenHAT participants with genome-wide microarray data. Participants were excluded if they had a genotype missing rate greater than 10% (<italic toggle="yes">n</italic> = 241), if there were discrepancies between self-reported and genotypic sex (<italic toggle="yes">n</italic> = 156), or if they were HapMap controls (<italic toggle="yes">n</italic> = 198), duplicates (<italic toggle="yes">n</italic> = 84), or genetic outliers (<italic toggle="yes">n</italic> = 6) as determined by SMARTPCA [<xref rid="B25-genes-13-01260" ref-type="bibr">25</xref>]. This resulted in a total of 6908 AA GenHAT participants, of which 4297 were randomized to chlorthalidone during ALLHAT. Furthermore, 320 participants were treatment naïve (i.e., they had not been previously treated for their hypertension, T-N) at randomization and were used in sensitivity models. </p>
              </sec>
              <sec id="sec2dot2-genes-13-01260">
                <title>2.2. ALLHAT Treatment</title>
                <p>Randomization drugs were titrated to meet the study treatment goal of SBP less than 140 mmHg and DBP less than 90 mmHg. Chlorthalidone was given once daily at 12.5 mg for the first and second titration and 25 mg for the third, and at the sixth month visit, the average chlorthalidone dose was 16.5 mg [<xref rid="B26-genes-13-01260" ref-type="bibr">26</xref>]. If BP control was not achieved on the maximum dose, a second-step drug (reserpine, clonidine, or atenolol), or a third-step agent (hydralazine) was added at the physician’s discretion [<xref rid="B26-genes-13-01260" ref-type="bibr">26</xref>]. </p>
              </sec>
              <sec id="sec2dot3-genes-13-01260">
                <title>2.3. Response Phenotypes</title>
                <p>The outcomes for the current study were the change in SBP and DBP from baseline to the six-month follow-up visit (ΔSBP = SBP<sub>6 month</sub> − SBP<sub>Baseline</sub>; ΔDBP = DBP<sub>6 month</sub> − DBP<sub>Baseline</sub>). Prior to BP measurement, participants were required to sit quietly in an erect, yet comfortable position with their feet flat on the ground for more than five minutes [<xref rid="B27-genes-13-01260" ref-type="bibr">27</xref>]. Blood pressure was measured at each time point and was calculated as the average of two measurements obtained with a 30-s interval between them [<xref rid="B28-genes-13-01260" ref-type="bibr">28</xref>]. Of the 4297 GenHAT participants, 3982 had baseline and six-month BP measures, of which 57% (<italic toggle="yes">n</italic> = 2269) were on chlorthalidone monotherapy at year 1. Of the 320 participants who were treatment-naïve at randomization, 290 had both BP measurements and 66% (<italic toggle="yes">n</italic> = 192) were on chlorthalidone monotherapy at year 1. </p>
                <p>Additionally, we measured the change in fasting glucose (ΔFG) over a 24-month period starting at baseline (ΔFG = FG<sub>24 month</sub> − FG<sub>Baseline</sub>). Both baseline and follow-up glucose concentrations were obtained after an overnight fast of at least 8 h. Analyses were done at a certified laboratory and detailed previously [<xref rid="B12-genes-13-01260" ref-type="bibr">12</xref>,<xref rid="B29-genes-13-01260" ref-type="bibr">29</xref>]. Of the 4297 GenHAT participants, 1127 had baseline and 24-month fasting glucose measures of which 67% (<italic toggle="yes">n</italic> = 757) were on chlorthalidone monotherapy at year 1 and 54% (<italic toggle="yes">n</italic> = 611) were on chlorthalidone monotherapy at year 2. Due to the small number of treatment naïve participants with two FG measures, secondary analyses on this subset were not performed.</p>
              </sec>
              <sec id="sec2dot4-genes-13-01260">
                <title>2.4. Genotyping and Imputation</title>
                <p>Genome-wide genotyping was performed using Illumina Infinium Multi-Ethnic AMR/AFR BeadChip arrays (Illumina Inc, San Diego, CA, USA), comprising over 1.4 million markers. Variants were excluded if they deviated from Hardy-Weinberg equilibrium (<italic toggle="yes">p</italic> &lt; 1 × 10<sup>−5</sup>), had a minor allele frequency (MAF) &lt;0.01, or had a missing rate &gt; 0.01. Furthermore, we analyzed the strand concordance, position, and allele assignment, resulting in 967,857 variants used in imputation. Imputation was performed using the NHLBI Trans-omics for Precision Medicine (TOPMed) Release 2 (Freeze 8) reference panel, which leverages data on &gt;50,000 AA samples [<xref rid="B30-genes-13-01260" ref-type="bibr">30</xref>,<xref rid="B31-genes-13-01260" ref-type="bibr">31</xref>,<xref rid="B32-genes-13-01260" ref-type="bibr">32</xref>]. Variants were excluded with imputation quality (r<sup>2</sup>) &lt; 0.3 or a minor allele count &lt;20, resulting in &gt;20.4 million used in association analysis.</p>
              </sec>
              <sec id="sec2dot5-genes-13-01260">
                <title>2.5. Statistical Analysis</title>
                <p>Descriptive statistics are presented as mean ± standard deviation (SD) for continuous traits and counts and percentages for categorical variables and were calculated using SAS version 9.4 (SAS Institute Inc., Cary, NC). Linear regression models were implemented in PLINK2 [<xref rid="B33-genes-13-01260" ref-type="bibr">33</xref>] for genome-wide association analyses of ΔSBP, ΔDBP, and ΔFG, independently, and assumed an additive model of inheritance. The ΔSBP and ΔDBP outcomes were z-transformed, with mean = 0 and SD = 1. The ΔFG outcome was inverse normal transformed using the RNOmni package in R [<xref rid="B34-genes-13-01260" ref-type="bibr">34</xref>]. Models of association between the BP/FG response to chlorthalidone and the imputed effect allele dosage were adjusted for age, sex, top 10 principal components to account for genetic ancestry, and corresponding baseline measure. Regional plots were created using LocusZoom v0.12 [<xref rid="B35-genes-13-01260" ref-type="bibr">35</xref>,<xref rid="B36-genes-13-01260" ref-type="bibr">36</xref>] and gene annotation was performed using ANNOVAR [<xref rid="B37-genes-13-01260" ref-type="bibr">37</xref>]. Genome-wide significance was set at <italic toggle="yes">p</italic> &lt; 5.00 × 10<sup>−8</sup> after a Bonferroni correction for each response phenotype.</p>
              </sec>
              <sec id="sec2dot6-genes-13-01260">
                <title>2.6. Replication Populations</title>
                <p>Replication was sought for both the main and secondary analyses using data facilitated through the International Consortium for Antihypertensive Pharmacogenomics Studies (ICAPS) between 1 February 2021 and 21 May 2021. We utilized genetic and phenotypic data from the Genetic Epidemiology of Responses to Antihypertensives (GERA) study [<xref rid="B38-genes-13-01260" ref-type="bibr">38</xref>], and the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR and PEAR-2) studies [<xref rid="B39-genes-13-01260" ref-type="bibr">39</xref>,<xref rid="B40-genes-13-01260" ref-type="bibr">40</xref>] (<uri>clinicaltrials.gov</uri> identifiers NCT00005520, NCT00246519, and NCT01203852, respectively). In PEAR and GERA, participants were randomized to hydrochlorothiazide (HCTZ), while in PEAR-2, participants were randomized to chlorthalidone. All three studies had a washout period of at least 4 weeks to establish hypertensive BPs before starting the drug treatment, making these populations more comparable to our secondary, treatment-naïve population. Furthermore, the response time was shorter for each of these studies in comparison with GenHAT (between 4–9 weeks) [<xref rid="B38-genes-13-01260" ref-type="bibr">38</xref>,<xref rid="B39-genes-13-01260" ref-type="bibr">39</xref>,<xref rid="B40-genes-13-01260" ref-type="bibr">40</xref>]. Details of the individual studies and participant demographics included in replication are available in <xref rid="app1-genes-13-01260" ref-type="app">Supplementary Materials</xref> and <xref rid="app1-genes-13-01260" ref-type="app">Table S1</xref>.</p>
                <p>The number of independent signals, as calculated by linkage disequilibrium (LD) r<sup>2</sup> &gt; 0.20 per phenotype, was used to calculate a Bonferroni-corrected α level for replication significance. For genome-wide significant discovery variants, replication significance was tested at α = 0.025 divided by the number of significant independent signals. Suggestive variants were tested at α =0.05 divided by the number of independent suggestive signals, as previously described [<xref rid="B41-genes-13-01260" ref-type="bibr">41</xref>].</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3-genes-13-01260">
              <title>3. Results</title>
              <p>The demographics for the GenHAT participants in this study are presented in <xref rid="genes-13-01260-t001" ref-type="table">Table 1</xref>. The average age of participants was 66 years and 41% of participants had T2D at baseline. The average baseline SBP and DBP were 146.14 mmHg and 84.86 mmHg, respectively. The average baseline FG was slightly elevated at 127.40 mg/dL and the serum potassium levels were 4.22 mmol/L (<xref rid="genes-13-01260-t001" ref-type="table">Table 1</xref>). The 290 participants who were treatment-naïve at baseline were similar in age to the larger population, but 28% had T2D and the average FG levels were lower at 118.59 mg/dL. The average SBP and DBP for these individuals were 155.92 mmHg and 90.43 mmHg, respectively (<xref rid="app1-genes-13-01260" ref-type="app">Table S2</xref>).</p>
              <p>GenHAT participants saw a reduction of nearly 6.7 mmHg for SBP and 3.1 mmHg for DBP over the six months. For FG there was an average increase of 6.7 mg/dL over 24 months (<xref rid="genes-13-01260-t002" ref-type="table">Table 2</xref>). For the subset of treatment naïve participants, larger responses were observed (−19.5 mmHg for SBP, −9.4 mmHg for DBP, and +10.3 mg/dL for FG, <xref rid="app1-genes-13-01260" ref-type="app">Table S3</xref>).</p>
              <p>Manhattan plots for the primary discovery analysis for BP response (ΔSBP and ΔDBP) are presented in <xref rid="genes-13-01260-f001" ref-type="fig">Figure 1</xref>. The treatment naïve analysis results (ΔSBP<sub>T-N</sub> and ΔDBP<sub>T-N</sub>) are reported in <xref rid="genes-13-01260-f002" ref-type="fig">Figure 2</xref>, and ΔFG is presented in <xref rid="app1-genes-13-01260" ref-type="app">Figure S1</xref>. The genomic inflation factor (λ) from the individual analyses ranged from (λ = 0.985 − 1.012) and showed no evidence of systematic inflation (<xref rid="app1-genes-13-01260" ref-type="app">Table S4</xref>; <xref rid="app1-genes-13-01260" ref-type="app">Figures S1 and S2</xref>).</p>
              <p>In <xref rid="genes-13-01260-t003" ref-type="table">Table 3</xref>, we present 14 top variants (<italic toggle="yes">p</italic> &lt; 1.00 × 10<sup>−7</sup>) associated with chlorthalidone BP response, 4 of which met the statistical significance criteria after Bonferroni correction (<italic toggle="yes">p</italic> &lt; 5.00 × 10<sup>−8</sup>). An additional 83 variants (42 for ΔDBP and 41 for ΔSBP) were suggestively associated (<italic toggle="yes">p</italic> &lt; 1.00 × 10<sup>−6</sup>) with BP response to chlorthalidone over six months (<xref rid="app1-genes-13-01260" ref-type="app">Tables S5 and S6</xref>). The most significant association in the current study was between the rare intronic cadherin related family member 2 (<italic toggle="yes">CDHR2</italic>) variant rs191702725 on chromosome 5 and ΔSBP (<italic toggle="yes">p</italic> = 2.40 × 10<sup>−9</sup>). On average, the GG genotype carriers observed a reduction of 6.79 mmHg over 6 months compared to an increase in BP (or non-response) with the carriers of the A effect allele (AA/GA) (<xref rid="app1-genes-13-01260" ref-type="app">Figure S3A</xref>). This rarer variant was not observed in any of the ICAPs data for replication (<xref rid="app1-genes-13-01260" ref-type="app">Table S5</xref>). The top variant for the ΔDBP analysis was rs10440665, an intergenic variant between <italic toggle="yes">LINC02211</italic> and <italic toggle="yes">CDH9</italic> on chromosome 5 (G allele, EAF = 26.7%, <italic toggle="yes">p</italic> = 4.48 × 10<sup>−8</sup>; <xref rid="genes-13-01260-t003" ref-type="table">Table 3</xref>). At this variant, persons homozygous for the effect allele G observed a 4.19 mmHg reduction in blood pressure compared to a 2.52 mmHg reduction observed in those homozygous for the A allele (<italic toggle="yes">p</italic> = 0.007) (<xref rid="genes-13-01260-t003" ref-type="table">Table 3</xref>, <xref rid="app1-genes-13-01260" ref-type="app">Figure S3B</xref>). An additional 12 variants in this intergenic region were associated with a stronger DBP response for the effect allele (<xref rid="app1-genes-13-01260" ref-type="app">Table S6</xref>; <xref rid="app1-genes-13-01260" ref-type="app">Figure S4</xref>). Additionally, two intergenic variants located downstream of <italic toggle="yes">FZD1</italic> were marginally associated with DBP response, rs7802445 (β = −0.84, <italic toggle="yes">p</italic> = 7.67 × 10<sup>−7</sup>) and rs79111780 (β = −0.84; <italic toggle="yes">p</italic> = 7.67 × 10<sup>−7</sup>) and had an EAF ~5%. In consideration of 12 independent signals for DBP response, no variant was replicated (α = 0.05/12). We did observe nominal replication for one of the <italic toggle="yes">LINC02211-CDH9</italic> intergenic variants in the GERA population, rs13164498 (<italic toggle="yes">p</italic> = 4.18 × 10<sup>−2</sup>), with the same direction of effect (<xref rid="app1-genes-13-01260" ref-type="app">Table S6</xref>). We also observed marginal replication (<italic toggle="yes">p</italic> &lt; 0.05) in PEAR-2 for both <italic toggle="yes">FZD1</italic> variants (rs7802445 [β = −3.71, <italic toggle="yes">p</italic> = 1.86 × 10<sup>−2</sup>] and rs79111780 [β = −3.67; <italic toggle="yes">p</italic> = 1.97 × 10<sup>−2</sup>]) (<xref rid="app1-genes-13-01260" ref-type="app">Table S6</xref>).</p>
              <p>In a subset of 290 participants who prior to ALLHAT randomization were not treated with an antihypertensive, we identified four statistically significant variants associated with SBP response (<xref rid="genes-13-01260-t004" ref-type="table">Table 4</xref>; <xref rid="genes-13-01260-f002" ref-type="fig">Figure 2</xref>). Of these, three variants were located within an intron of the CACNA1C gene, with an additional CACNA1C intronic variant reaching suggestive significance (<xref rid="app1-genes-13-01260" ref-type="app">Figure S5</xref>). The top variant was rs114758661 and was significantly associated (<italic toggle="yes">p</italic> = 1.12 × 10<sup>−8</sup>) with SBP response. Compared to an increase/non-response in BP with G-allele carriers (GG/GA), non-carriers (AA) had an average reduction of 20.39 mmHg SBP (<italic toggle="yes">p</italic> &lt; 0.0001) (<xref rid="app1-genes-13-01260" ref-type="app">Figure S3C</xref>). We did not observe any replication for the CACNA1C variants in the PEAR or PEAR-2 populations (replication threshold for independent significant signals = 0.025/2 independent signals = 1.25 × 10<sup>−2</sup>). Furthermore, we report 19 suggestive intronic variants of LTBP1 in the treatment naïve SBP response analysis (<italic toggle="yes">p</italic>-value ranges from <italic toggle="yes">p</italic> = 1.52 × 10<sup>−7</sup> to <italic toggle="yes">p</italic> = 8.30 × 10<sup>−7</sup>). There was marginal replication in PEAR for four of these variants (<italic toggle="yes">p</italic> &lt; 0.05) with the same direction of effect (<xref rid="app1-genes-13-01260" ref-type="app">Table S7</xref>). Additionally, we observed four variants with a marginal association with ΔDBP in the intergenic region between CYSLTR2 and FNDC3A (<italic toggle="yes">p</italic> = 7.78 × 10<sup>−7</sup>) for the treatment-naïve participants (<xref rid="app1-genes-13-01260" ref-type="app">Table S8</xref>). </p>
              <p>In our ΔFG analysis, we observed nine statistically significant variants and an additional 49 variants with <italic toggle="yes">p</italic> &lt; 1.00 × 10<sup>−6</sup> (<xref rid="app1-genes-13-01260" ref-type="app">Table S9</xref>; <xref rid="app1-genes-13-01260" ref-type="app">Figure S1</xref>). The top five associated variants were all located within 16 kb of each other in the GIMAP1-GIMAP5 read-through region on chromosome 7 (<xref rid="app1-genes-13-01260" ref-type="app">Figure S6</xref>) and have an allele frequency of 0.9%. Of these GIMAP variants, none were replicated with genome-wide significance (α =0.025/5 independent signals for ΔFG =5.00 × 10<sup>−3</sup>) (<xref rid="app1-genes-13-01260" ref-type="app">Table S9</xref>).</p>
              <p>Additionally, we aimed to replicate previously published variants associated with BP or FG response to thiazide diuretic mono- or combination-therapy in AA or EA populations (<xref rid="app1-genes-13-01260" ref-type="app">Supplementary Tables S10 and S11</xref>). We identified 75 variants, mapping to or near 63 unique genes, in the literature dating back to 2010 associated with BP response to thiazide diuretics. We found marginal associations (<italic toggle="yes">p</italic> &lt; 0.05) with three published variants, rs3758785, rs12505746, and rs321320, in the ΔSBP results (<italic toggle="yes">SNN-TXNDC11</italic>, <italic toggle="yes">TET2</italic>, and <italic toggle="yes">CLIC5-RUNX2</italic> regions, respectively); six variants, rs1802409, rs12505746, rs4551053, rs238, rs822127, and rs9590353 in the ΔDBP results (<italic toggle="yes">SNN-TXNDC11, TET2, EBF1, LINC00092, PLCXD3-OXTC1,</italic> and <italic toggle="yes">UGGT2</italic> regions, respectively); and three variants, rs1458038, rs12505746, and rs4757718, in the treatment-naïve ΔDBP results (<italic toggle="yes">FGF5, TET2,</italic> and <italic toggle="yes">PTPN5</italic>, respectively) (<xref rid="app1-genes-13-01260" ref-type="app">Table S10</xref>). We identified 40 variants in the literature dating back to 2010 associated with FG response to thiazide diuretics and one with the nominal association in our FG analysis, rs7077606 near <italic toggle="yes">PCDH15</italic> (<xref rid="app1-genes-13-01260" ref-type="app">Table S11</xref>).</p>
            </sec>
            <sec sec-type="discussion" id="sec4-genes-13-01260">
              <title>4. Discussion</title>
              <p>Antihypertensives are one of the most prescribed medications in the United States, and chlorthalidone is a recommended first-line therapy for treating HTN, particularly in AAs [<xref rid="B7-genes-13-01260" ref-type="bibr">7</xref>]. The discovery of genetic variants that associate with the BP response to chlorthalidone may help improve treatment outcomes. In the current study, we aimed to identify any genetic contributors to the efficacy of chlorthalidone in 4297 AAs from GenHAT. Furthermore, we elucidated genetic variation associated with changes in FG in these participants. Using a genome-wide approach, we identified eight significant variants associated with BP response (3 for ΔSBP, 1 for ΔDBP, and 4 for ΔSBP<sub>T-N</sub>) and nine significant variants associated with FG response to chlorthalidone.</p>
              <p>For DBP response, the most significant region was located upstream of <italic toggle="yes">CDH9</italic>. <italic toggle="yes">CDH9</italic> encodes cadherin 9, a type II classical cadherin from the cadherin superfamily, whose function is to mediate cell-cell adhesion [<xref rid="B42-genes-13-01260" ref-type="bibr">42</xref>]. An intronic variant of <italic toggle="yes">CDH9</italic> was previously implicated in coronary artery calcification (CAC) in AAs [<xref rid="B43-genes-13-01260" ref-type="bibr">43</xref>]. Compared to other antihypertensives (CCB nifedipine), thiazide diuretics are associated with a faster progression of CAC in hypertensive patients [<xref rid="B44-genes-13-01260" ref-type="bibr">44</xref>]. Furthermore, <italic toggle="yes">CDH9</italic> has been described as a reliable cell surface marker for renal fibroblasts, the primary matrix-producing cells in the kidney [<xref rid="B45-genes-13-01260" ref-type="bibr">45</xref>,<xref rid="B46-genes-13-01260" ref-type="bibr">46</xref>], which are involved in BP regulation [<xref rid="B47-genes-13-01260" ref-type="bibr">47</xref>]. These previous reports add biological support to this intergenic locus possibly through a regulatory role (given the location of these variants). </p>
              <p>In our treatment-naive secondary analyses, we reported three significant variants in <italic toggle="yes">CACNA1C</italic> for ΔSBP. <italic toggle="yes">CACNA1C</italic> encodes the calcium voltage-gated channel subunit α 1C. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization [<xref rid="B42-genes-13-01260" ref-type="bibr">42</xref>] and are involved in several physiological processes including vascular and smooth muscle contraction, which is important in BP regulation [<xref rid="B48-genes-13-01260" ref-type="bibr">48</xref>,<xref rid="B49-genes-13-01260" ref-type="bibr">49</xref>]. Genetic variation within <italic toggle="yes">CACNA1C</italic> has been reported to affect CCB efficacy in previous pharmacogenomic studies of HTN [<xref rid="B50-genes-13-01260" ref-type="bibr">50</xref>,<xref rid="B51-genes-13-01260" ref-type="bibr">51</xref>,<xref rid="B52-genes-13-01260" ref-type="bibr">52</xref>]. Findings in over 1700 Han Chinese individuals from the Genetic Epidemiology Network of Salt Sensitivity (GenSalt), reported <italic toggle="yes">CACNA1C</italic> as a potential genetic contributor to BP variation over time in both single-variant and gene-based analyses [<xref rid="B53-genes-13-01260" ref-type="bibr">53</xref>]. </p>
              <p>The variants of additional interest due to their biological plausibility included two intergenic variants downstream of <italic toggle="yes">FZD1</italic> (ΔDBP)<italic toggle="yes">,</italic> 18 intronic variants of <italic toggle="yes">LTBP1</italic> (ΔSBP<sub>T-N</sub>), and four intergenic variants upstream of <italic toggle="yes">CYSLTR2</italic> (ΔDBP<sub>T-N</sub>). The <italic toggle="yes">FZD1</italic> gene encodes the frizzled class receptor 1, a member of the “frizzled” family of membrane domain proteins that functions as receptors for Wnt signaling proteins [<xref rid="B42-genes-13-01260" ref-type="bibr">42</xref>]. The relationship between Wnt/β-catenin signaling and hypertension is well documented, evidenced through genome-wide association studies in AA [<xref rid="B14-genes-13-01260" ref-type="bibr">14</xref>] and EA [<xref rid="B54-genes-13-01260" ref-type="bibr">54</xref>] populations, murine in vivo models [<xref rid="B55-genes-13-01260" ref-type="bibr">55</xref>], and through cardiac function [<xref rid="B56-genes-13-01260" ref-type="bibr">56</xref>,<xref rid="B57-genes-13-01260" ref-type="bibr">57</xref>]. Furthermore, <italic toggle="yes">FZD1</italic> has been independently described as an essential mediator of cardiac hypertrophy (Fan et al., 2018). <italic toggle="yes">LTBP1</italic> encodes the latent transforming growth factor β binding protein 1, a key regulator of transforming growth factor β activation [<xref rid="B42-genes-13-01260" ref-type="bibr">42</xref>]. Anomalous expression of <italic toggle="yes">LTBP1</italic> has been previously detected in thoracic aortic aneurysms [<xref rid="B58-genes-13-01260" ref-type="bibr">58</xref>] and may promote the development of arterial diseases [<xref rid="B59-genes-13-01260" ref-type="bibr">59</xref>]. <italic toggle="yes">LTBP1</italic> has been implicated as a primary regulator of the effect of lethal (3) malignant brain tumor-like protein 4 (L3MBTL4 protein) on vascular remodeling and HTN [<xref rid="B60-genes-13-01260" ref-type="bibr">60</xref>]. The four variants located within an intergenic region of <italic toggle="yes">CYSLTR2</italic> and <italic toggle="yes">FNDC3A</italic> were marginally associated with ΔDBP in treatment-naive participants and were in strong LD (r<sup>2</sup> &gt; 0.9). <italic toggle="yes">CYSLTR2</italic> encodes the cysteinyl leukotriene receptor 2 (CysLT<sub>2</sub>R). <italic toggle="yes">CYSLTR2</italic> is highly expressed in the heart and coronary vessels [<xref rid="B61-genes-13-01260" ref-type="bibr">61</xref>], and in addition to the cysteinyl leukotriene receptor 1, mediates the actions of inflammatory mediators (e.g., cysteinyl leukotrienes, leukotriene C<sub>4</sub>, leukotriene D<sub>4</sub>, and leukotriene E<sub>4</sub>) affecting smooth muscle construction and vascular permeability [<xref rid="B62-genes-13-01260" ref-type="bibr">62</xref>,<xref rid="B63-genes-13-01260" ref-type="bibr">63</xref>]. A 2004 study performed in endothelial cell specific human CysLT<sub>2</sub>R transgenic mice reported distinct vascular effects of cysteinyl leukotrienes mediated via CysLT<sub>2</sub>R [<xref rid="B61-genes-13-01260" ref-type="bibr">61</xref>].</p>
              <p>In the ΔFG analysis, we identified five statistically significant variants in the <italic toggle="yes">GIMAP1-GIMAP5</italic> naturally occurring read-through region. The GIMAPs (GTPases of the immunity-associated proteins) are a family of GTPases that are expressed in the immune system [<xref rid="B42-genes-13-01260" ref-type="bibr">42</xref>]. <italic toggle="yes">GIMAP</italic> GTPase family genes, <italic toggle="yes">GIMAP4</italic> and <italic toggle="yes">GIMAP5</italic>, have been previously described as potential modifiers of immune-mediated diseases, such as type 1 diabetes, asthma, and allergic sensitization [<xref rid="B64-genes-13-01260" ref-type="bibr">64</xref>]. The <italic toggle="yes">GIMAP1-GIMAP5</italic> region was previously associated with CAC in AAs with T2D [<xref rid="B65-genes-13-01260" ref-type="bibr">65</xref>]. To our knowledge, no other study has described genetic variation in this read-through region in relation to the change in FG or BP during antihypertensive treatment. This gene region was not replicated; therefore, additional studies are needed to determine if this locus is relevant to FG changes during treatment.</p>
              <p>In the lookup analysis of previously published pharmacogenomic studies on thiazide diuretics and BP, we observed marginal associations with variants located within or near <italic toggle="yes">SNN-TXNDC11</italic>, <italic toggle="yes">TET2</italic>, <italic toggle="yes">CLIC5-RUNX2</italic>, <italic toggle="yes">EBF1</italic>, <italic toggle="yes">PLCXD3-OXTC1</italic>, <italic toggle="yes">UGGT2</italic>, <italic toggle="yes">FGF5</italic>, and <italic toggle="yes">PTPN5</italic>. Of these suggestive associations, the most biologically relevant include variants within <italic toggle="yes">FGF5</italic> (Fibroblast Growth Factor 5), <italic toggle="yes">TET2</italic> (Tet Methylcytosine Dioxygenase 2), <italic toggle="yes">CLIC5</italic> (chloride intracellular channel 5), and the <italic toggle="yes">EBF1</italic> (early B-cell factor 1). <italic toggle="yes">FGF5</italic> has previously been implicated as a susceptibly region for primary hypertension [<xref rid="B66-genes-13-01260" ref-type="bibr">66</xref>,<xref rid="B67-genes-13-01260" ref-type="bibr">67</xref>], while <italic toggle="yes">TET2</italic> has been implicated as an aldosterone responsive mediator of α epithelial sodium channel transcription (which has a role in BP regulation) [<xref rid="B68-genes-13-01260" ref-type="bibr">68</xref>]. <italic toggle="yes">CLIC5</italic> functions in the maintenance of renal glomerular architecture of podocytes and endothelial cells, but it is unknown whether it functions in thiazide action [<xref rid="B69-genes-13-01260" ref-type="bibr">69</xref>,<xref rid="B70-genes-13-01260" ref-type="bibr">70</xref>]. <italic toggle="yes">EBF1</italic> is a transcription factor with the hematopoietic function that has been associated with early onset coronary artery disease [<xref rid="B71-genes-13-01260" ref-type="bibr">71</xref>]. In a large meta-analysis of BP traits, rs4551053, an upstream variant of <italic toggle="yes">EBF1,</italic> was significantly associated with SBP (<italic toggle="yes">p</italic> = 1.17 × 10<sup>−47</sup>), DBP (<italic toggle="yes">p</italic> = 2.98 × 10<sup>−40</sup>), and pulse pressure (2.82 × 10<sup>−23</sup>) in 700,000 EAs [<xref rid="B72-genes-13-01260" ref-type="bibr">72</xref>].</p>
              <p>The current study has several strengths. As an ancillary study to ALLHAT, one of the largest antihypertensive clinical trials to date, GenHAT is a rich data source for pharmacogenomic analysis. Additionally, we utilized the ancestrally diverse Illumina Multi-Ethnic array and TOPMed reference panel for imputation which includes ~25% individuals of African ancestry, allowing for improved coverage of African ancestral genomes and rare variant inclusion not possible with previous arrays and a 1000 G reference panel [<xref rid="B32-genes-13-01260" ref-type="bibr">32</xref>]. This study has some limitations as well. As we have noted, we completed secondary analyses on 290 AA participants who were treatment-naive at ALLHAT randomization. While this number is on par with several other published pharmacogenomic studies evaluating thiazide diuretic efficacy [<xref rid="B73-genes-13-01260" ref-type="bibr">73</xref>,<xref rid="B74-genes-13-01260" ref-type="bibr">74</xref>,<xref rid="B75-genes-13-01260" ref-type="bibr">75</xref>], the primary analyses were performed on a population where the majority were already taking an antihypertensive agent. Furthermore, BP measurement is prone to error, but BP for this study was measured twice after a participant had been seated quietly for at least five minutes by trained staff using standardized procedures across all centers in the ALLHAT study. Most of the significant variants we identified had EAF between 1–5% (apart from the intergenic <italic toggle="yes">LINC02211-CDH9</italic> variants), making it difficult to replicate, especially in cohorts with limited genetic data in AAs. Lastly, a common limitation of GWAS are the small effect sizes for the observed results, thus suggesting further validation.</p>
              <p>Given the significant burden of HTN in AAs, strategies to improve BP control are of high priority. Identifying genetic variation associated with BP response and/or adverse metabolic effects may lead to drug optimization in these individuals. Although we identified eight variants statistically associated with BP response to chlorthalidone and an additional nine variants associated with the change in FG, none of these results were replicated across all three replication cohorts. Regardless, our findings still have biological plausibility, and further investigation into these variants and gene regions are warranted. Ultimately, understanding the genetic risk factors for both BP control and glucose dysregulation during chlorthalidone treatment continues to be an important research avenue to prevent excess CVD risk in AAs.</p>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p><bold>Publisher’s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <app-group>
              <app id="app1-genes-13-01260">
                <title>Supplementary Materials</title>
                <p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/genes13071260/s1">https://www.mdpi.com/article/10.3390/genes13071260/s1</uri>, Figure S1: Manhattan and QQ plot for the FG analysis results; Figure S2: QQ plots for the discovery BP response analysis; Figure S3: Marginal mean blood pressure response by genotype; Figure S4: LocusZoom regional plot for rs10440665 in the intergenic region on chromosome 5 between <italic toggle="yes">LINC02211</italic> and <italic toggle="yes">CDH9</italic>; Figure S5: LocusZoom regional plot for rs114758661 in the intronic region of <italic toggle="yes">CACNA1C</italic> on chromosome 12; Figure S6: LocusZoom regional plot for rs79772702 in the <italic toggle="yes">GIMAP1-GIMAP5</italic> readthrough region on chromosome 7. Table S1: Demographics of participants included in ICAPS validation; Table S2: Baseline Demographics of GenHAT Treatment-Naive Participants for ΔBP Analysis; Table S3: Chlorthalidone Blood Pressure and Glucose Response in Treatment-Naive Participants; Table S4: GenHAT discovery analyses genomic control (λ) values; Table S5: Top variants (<italic toggle="yes">p</italic> &lt; 1.00 × 10<sup>−6</sup>) from the GenHAT ΔSBP response; Table S6: Top variants (<italic toggle="yes">p</italic> &lt; 1.00 × 10<sup>−6</sup>) from the GenHAT ΔDBP response; Table S7: Top variants (<italic toggle="yes">p</italic> &lt; 1.00 × 10<sup>−6</sup>) from the GenHAT ΔSBP response in 290 treatment-naive participants; Table S8: Top variants (<italic toggle="yes">p</italic> &lt; 1.00 × 10<sup>−6</sup>) from the GenHAT DBP response in 290 treatment-naive participants; Table S9: Top variants (<italic toggle="yes">p</italic> &lt; 1.00 × 10<sup>−6</sup>) from the GenHAT ΔFG response; Table S10: Previously published (since 2010) variants associated with BP response to thiazide diuretics mono- or combination-therapy; Table S11: Previously published (since 2010) antihypertensive pharmacogenomic studies associated with glycemic traits [<xref rid="B76-genes-13-01260" ref-type="bibr">76</xref>].</p>
                <supplementary-material id="genes-13-01260-s001" position="float" content-type="local-data">
                  <media xlink:href="genes-13-01260-s001.zip">
                    <caption>
                      <p>Click here for additional data file.</p>
                    </caption>
                  </media>
                </supplementary-material>
              </app>
            </app-group>
            <notes>
              <title>Author Contributions</title>
              <p>Conceptualization, N.D.A., D.K.A. and M.R.I.; Data curation, V.S. and R.M.T.; Formal analysis, N.D.A. and V.S.; Funding acquisition, J.A.J. and M.R.I.; Investigation, N.D.A., A.C.J., R.M.T., B.A.H., N.A.L. and M.R.I.; Supervision, D.K.A. and M.R.I.; Validation, L.M.S.C., N.H.K.N., N.A.N., Y.G., C.W.M., R.M.C.-D. and J.A.J.; Visualization, N.D.A. and S.A.C.; Writing—original draft, N.D.A. and M.R.I.; Writing—review &amp; editing, N.D.A., V.S., L.M.S.C., N.H.K.N., N.A.N., A.C.J., R.M.T., B.A.H., N.A.L., S.A.C., Y.G., C.W.M., R.M.C.-D., J.A.J., H.K.T., D.K.A. and M.R.I. All authors have read and agreed to the published version of the manuscript.</p>
            </notes>
            <notes>
              <title>Institutional Review Board Statement</title>
              <p>The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of The University of Alabama at Birmingham (IRB-160415008) on 25 April 2018.</p>
            </notes>
            <notes>
              <title>Informed Consent Statement</title>
              <p>Written, informed consent was obtained from all participants involved in the study.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data Availability Statement</title>
              <p>The raw GenHAT genotypic and phenotypic data used in this study are deposited in the National Center for Biotechnology Information (NCBI) Database for Genotypes and Phenotypes (dbGaP), accession number phs002716.v1.p1. The data for the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study and PEAR-2 have been made publicly available in dbGaP under accession: phs000649.v2.p2.</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>The authors declare no conflict of interest.</p>
            </notes>
            <ref-list>
              <title>References</title>
              <ref id="B1-genes-13-01260">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Forouzanfar</surname>
                      <given-names>M.H.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Roth</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Ng</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Biryukov</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Marczak</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Alexander</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Estep</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Abate</surname>
                      <given-names>K.H.</given-names>
                    </name>
                    <name>
                      <surname>Akinyemiju</surname>
                      <given-names>T.F.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990–2015</article-title>
                  <source>JAMA</source>
                  <year>2017</year>
                  <volume>317</volume>
                  <fpage>165</fpage>
                  <lpage>182</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2016.19043</pub-id>
                  <?supplied-pmid 28097354?>
                  <pub-id pub-id-type="pmid">28097354</pub-id>
                </element-citation>
              </ref>
              <ref id="B2-genes-13-01260">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>Sprint Research Group</collab>
                    <name>
                      <surname>Lewis</surname>
                      <given-names>C.E.</given-names>
                    </name>
                    <name>
                      <surname>Fine</surname>
                      <given-names>L.J.</given-names>
                    </name>
                    <name>
                      <surname>Beddhu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Cheung</surname>
                      <given-names>A.K.</given-names>
                    </name>
                    <name>
                      <surname>Cushman</surname>
                      <given-names>W.C.</given-names>
                    </name>
                    <name>
                      <surname>Cutler</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Evans</surname>
                      <given-names>G.W.</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>K.C.</given-names>
                    </name>
                    <name>
                      <surname>Kitzman</surname>
                      <given-names>D.W.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Final Report of a Trial of Intensive versus Standard Blood-Pressure Control</article-title>
                  <source>N. Engl. J. Med.</source>
                  <year>2021</year>
                  <volume>384</volume>
                  <fpage>1921</fpage>
                  <lpage>1930</lpage>
                  <?supplied-pmid 34010531?>
                  <pub-id pub-id-type="pmid">34010531</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-genes-13-01260">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Virani</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Alonso</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Aparicio</surname>
                      <given-names>H.J.</given-names>
                    </name>
                    <name>
                      <surname>Benjamin</surname>
                      <given-names>E.J.</given-names>
                    </name>
                    <name>
                      <surname>Bittencourt</surname>
                      <given-names>M.S.</given-names>
                    </name>
                    <name>
                      <surname>Callaway</surname>
                      <given-names>C.W.</given-names>
                    </name>
                    <name>
                      <surname>Carson</surname>
                      <given-names>A.P.</given-names>
                    </name>
                    <name>
                      <surname>Chamberlain</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Delling</surname>
                      <given-names>F.N.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Heart Disease and Stroke Statistics–2021 Update: A Report From the American Heart Association</article-title>
                  <source>Circulation</source>
                  <year>2021</year>
                  <volume>143</volume>
                  <fpage>e254</fpage>
                  <lpage>e743</lpage>
                  <pub-id pub-id-type="doi">10.1161/CIR.0000000000000950</pub-id>
                  <?supplied-pmid 33501848?>
                  <pub-id pub-id-type="pmid">33501848</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-genes-13-01260">
                <label>4.</label>
                <element-citation publication-type="gov">
                  <person-group person-group-type="author">
                    <collab>Centers for Disease Control and Prevention, National Center for Health Statistics</collab>
                  </person-group>
                  <article-title>National Health and Nutrition Examination Survey (NHANES) Public Use Data Files, 2015–2018</article-title>
                  <comment>Available online: <ext-link xlink:href="https://www.cdc.gov/nchs/nhanes/" ext-link-type="uri">https://www.cdc.gov/nchs/nhanes/</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-04-01">(accessed on 1 April 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B5-genes-13-01260">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fryar</surname>
                      <given-names>C.D.</given-names>
                    </name>
                    <name>
                      <surname>Ostchega</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Hales</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Kruszon-Moran</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Hypertension Prevalence and Control Among Adults: United States, 2015–2016</article-title>
                  <source>NCHS Data Brief.</source>
                  <year>2017</year>
                  <volume>289</volume>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                </element-citation>
              </ref>
              <ref id="B6-genes-13-01260">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lackland</surname>
                      <given-names>D.T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Racial differences in hypertension: Implications for high blood pressure management</article-title>
                  <source>Am. J. Med. Sci.</source>
                  <year>2014</year>
                  <volume>348</volume>
                  <fpage>135</fpage>
                  <lpage>138</lpage>
                  <pub-id pub-id-type="doi">10.1097/MAJ.0000000000000308</pub-id>
                  <pub-id pub-id-type="pmid">24983758</pub-id>
                </element-citation>
              </ref>
              <ref id="B7-genes-13-01260">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>James</surname>
                      <given-names>P.A.</given-names>
                    </name>
                    <name>
                      <surname>Oparil</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Carter</surname>
                      <given-names>B.L.</given-names>
                    </name>
                    <name>
                      <surname>Cushman</surname>
                      <given-names>W.C.</given-names>
                    </name>
                    <name>
                      <surname>Dennison-Himmelfarb</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Handler</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Lackland</surname>
                      <given-names>D.T.</given-names>
                    </name>
                    <name>
                      <surname>LeFevre</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>MacKenzie</surname>
                      <given-names>T.D.</given-names>
                    </name>
                    <name>
                      <surname>Ogedegbe</surname>
                      <given-names>O.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)</article-title>
                  <source>JAMA</source>
                  <year>2014</year>
                  <volume>311</volume>
                  <fpage>507</fpage>
                  <lpage>520</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2013.284427</pub-id>
                  <pub-id pub-id-type="pmid">24352797</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-genes-13-01260">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Johnson</surname>
                      <given-names>J.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Ethnic differences in cardiovascular drug response: Potential contribution of pharmacogenetics</article-title>
                  <source>Circulation</source>
                  <year>2008</year>
                  <volume>118</volume>
                  <fpage>1383</fpage>
                  <lpage>1393</lpage>
                  <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.704023</pub-id>
                  <pub-id pub-id-type="pmid">18809808</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-genes-13-01260">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Whelton</surname>
                      <given-names>P.K.</given-names>
                    </name>
                    <name>
                      <surname>Carey</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Aronow</surname>
                      <given-names>W.S.</given-names>
                    </name>
                    <name>
                      <surname>Casey</surname>
                      <given-names>D.E.</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                    <name>
                      <surname>Collins</surname>
                      <given-names>K.J.</given-names>
                    </name>
                    <name>
                      <surname>Dennison Himmelfarb</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>DePalma</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Gidding</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Jamerson</surname>
                      <given-names>K.A.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>D.W.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines</article-title>
                  <source>Circulation</source>
                  <year>2018</year>
                  <volume>138</volume>
                  <fpage>e426</fpage>
                  <lpage>e483</lpage>
                  <pub-id pub-id-type="pmid">30354655</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-genes-13-01260">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roush</surname>
                      <given-names>G.C.</given-names>
                    </name>
                    <name>
                      <surname>Buddharaju</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Ernst</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>Holford</surname>
                      <given-names>T.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Chlorthalidone: Mechanisms of action and effect on cardiovascular events</article-title>
                  <source>Curr. Hypertens. Rep.</source>
                  <year>2013</year>
                  <volume>15</volume>
                  <fpage>514</fpage>
                  <lpage>521</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11906-013-0372-1</pub-id>
                  <pub-id pub-id-type="pmid">23839110</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-genes-13-01260">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>Q.</given-names>
                    </name>
                  </person-group>
                  <article-title>Association of Thiazide-Type Diuretics With Glycemic Changes in Hypertensive Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials</article-title>
                  <source>J. Clin. Hypertens.</source>
                  <year>2016</year>
                  <volume>18</volume>
                  <fpage>342</fpage>
                  <lpage>351</lpage>
                  <pub-id pub-id-type="doi">10.1111/jch.12679</pub-id>
                </element-citation>
              </ref>
              <ref id="B12-genes-13-01260">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barzilay</surname>
                      <given-names>J.I.</given-names>
                    </name>
                    <name>
                      <surname>Davis</surname>
                      <given-names>B.R.</given-names>
                    </name>
                    <name>
                      <surname>Cutler</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Pressel</surname>
                      <given-names>S.L.</given-names>
                    </name>
                    <name>
                      <surname>Whelton</surname>
                      <given-names>P.K.</given-names>
                    </name>
                    <name>
                      <surname>Basile</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Margolis</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Ong</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <name>
                      <surname>Sadler</surname>
                      <given-names>L.S.</given-names>
                    </name>
                    <name>
                      <surname>Summerson</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)</article-title>
                  <source>Arch. Intern. Med.</source>
                  <year>2006</year>
                  <volume>166</volume>
                  <fpage>2191</fpage>
                  <lpage>2201</lpage>
                  <pub-id pub-id-type="pmid">17101936</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-genes-13-01260">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Johnson</surname>
                      <given-names>J.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Advancing management of hypertension through pharmacogenomics</article-title>
                  <source>Ann. Med.</source>
                  <year>2012</year>
                  <volume>44</volume>
                  <issue>(Suppl. 1)</issue>
                  <fpage>S17</fpage>
                  <lpage>S22</lpage>
                  <pub-id pub-id-type="doi">10.3109/07853890.2011.653399</pub-id>
                  <pub-id pub-id-type="pmid">22713143</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-genes-13-01260">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Adeyemo</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Gerry</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Herbert</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Doumatey</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Lashley</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Christman</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A genome-wide association study of hypertension and blood pressure in African Americans</article-title>
                  <source>PLoS Genet.</source>
                  <year>2009</year>
                  <volume>5</volume>
                  <elocation-id>e1000564</elocation-id>
                  <pub-id pub-id-type="doi">10.1371/journal.pgen.1000564</pub-id>
                  <pub-id pub-id-type="pmid">19609347</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-genes-13-01260">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Basson</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Simino</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Rao</surname>
                      <given-names>D.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Between candidate genes and whole genomes: Time for alternative approaches in blood pressure genetics</article-title>
                  <source>Curr. Hypertens. Rep.</source>
                  <year>2012</year>
                  <volume>14</volume>
                  <fpage>46</fpage>
                  <lpage>61</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11906-011-0241-8</pub-id>
                  <pub-id pub-id-type="pmid">22161147</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-genes-13-01260">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Doris</surname>
                      <given-names>P.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>The genetics of blood pressure and hypertension: The role of rare variation</article-title>
                  <source>Cardiovasc. Ther.</source>
                  <year>2011</year>
                  <volume>29</volume>
                  <fpage>37</fpage>
                  <lpage>45</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1755-5922.2010.00246.x</pub-id>
                  <pub-id pub-id-type="pmid">21129164</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-genes-13-01260">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kato</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Loh</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Takeuchi</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Verweij</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Kelly</surname>
                      <given-names>T.N.</given-names>
                    </name>
                    <name>
                      <surname>Saleheen</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Lehne</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Leach</surname>
                      <given-names>I.M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation</article-title>
                  <source>Nat. Genet.</source>
                  <year>2015</year>
                  <volume>47</volume>
                  <fpage>1282</fpage>
                  <lpage>1293</lpage>
                  <pub-id pub-id-type="doi">10.1038/ng.3405</pub-id>
                  <pub-id pub-id-type="pmid">26390057</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-genes-13-01260">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kraja</surname>
                      <given-names>A.T.</given-names>
                    </name>
                    <name>
                      <surname>Hunt</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Rao</surname>
                      <given-names>D.C.</given-names>
                    </name>
                    <name>
                      <surname>Davila-Roman</surname>
                      <given-names>V.G.</given-names>
                    </name>
                    <name>
                      <surname>Arnett</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Province</surname>
                      <given-names>M.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Genetics of hypertension and cardiovascular disease and their interconnected pathways: Lessons from large studies</article-title>
                  <source>Curr. Hypertens. Rep.</source>
                  <year>2011</year>
                  <volume>13</volume>
                  <fpage>46</fpage>
                  <lpage>54</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11906-010-0174-7</pub-id>
                  <pub-id pub-id-type="pmid">21128019</pub-id>
                </element-citation>
              </ref>
              <ref id="B19-genes-13-01260">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rao</surname>
                      <given-names>D.C.</given-names>
                    </name>
                    <name>
                      <surname>Province</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Leppert</surname>
                      <given-names>M.F.</given-names>
                    </name>
                    <name>
                      <surname>Oberman</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Heiss</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Ellison</surname>
                      <given-names>R.C.</given-names>
                    </name>
                    <name>
                      <surname>Arnett</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Eckfeldt</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Schwander</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Mockrin</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A genome-wide affected sibpair linkage analysis of hypertension: The HyperGEN network</article-title>
                  <source>Am. J. Hypertens.</source>
                  <year>2003</year>
                  <volume>16</volume>
                  <fpage>148</fpage>
                  <lpage>150</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0895-7061(02)03247-8</pub-id>
                  <pub-id pub-id-type="pmid">12559683</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-genes-13-01260">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Simino</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Shi</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Kume</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Schwander</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Province</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Gu</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Kardia</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Chakravarti</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Ehret</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Olshen</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Five blood pressure loci identified by an updated genome-wide linkage scan: Meta-analysis of the Family Blood Pressure Program</article-title>
                  <source>Am. J. Hypertens.</source>
                  <year>2011</year>
                  <volume>24</volume>
                  <fpage>347</fpage>
                  <lpage>354</lpage>
                  <pub-id pub-id-type="doi">10.1038/ajh.2010.238</pub-id>
                  <pub-id pub-id-type="pmid">21151011</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-genes-13-01260">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sung</surname>
                      <given-names>Y.J.</given-names>
                    </name>
                    <name>
                      <surname>Basson</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Nguyen</surname>
                      <given-names>K.D.</given-names>
                    </name>
                    <name>
                      <surname>Nandakumar</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Hunt</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Arnett</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Dávila-Román</surname>
                      <given-names>V.G.</given-names>
                    </name>
                    <name>
                      <surname>Rao</surname>
                      <given-names>D.C.</given-names>
                    </name>
                    <name>
                      <surname>Chakravarti</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>The role of rare variants in systolic blood pressure: Analysis of ExomeChip data in HyperGEN African Americans</article-title>
                  <source>Hum. Hered.</source>
                  <year>2015</year>
                  <volume>79</volume>
                  <fpage>20</fpage>
                  <lpage>27</lpage>
                  <pub-id pub-id-type="doi">10.1159/000375373</pub-id>
                  <pub-id pub-id-type="pmid">25765051</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-genes-13-01260">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Young</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Fox</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Keating</surname>
                      <given-names>B.J.</given-names>
                    </name>
                    <name>
                      <surname>Franceschini</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Kang</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Tayo</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Adeyemo</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>Y.V.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Combined admixture mapping and association analysis identifies a novel blood pressure genetic locus on 5p13: Contributions from the CARe consortium</article-title>
                  <source>Hum. Mol. Genet.</source>
                  <year>2011</year>
                  <volume>20</volume>
                  <fpage>2285</fpage>
                  <lpage>2295</lpage>
                  <pub-id pub-id-type="doi">10.1093/hmg/ddr113</pub-id>
                  <pub-id pub-id-type="pmid">21422096</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-genes-13-01260">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>ALLHAT Collaborative Research Group</collab>
                  </person-group>
                  <article-title>Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)</article-title>
                  <source>JAMA</source>
                  <year>2000</year>
                  <volume>283</volume>
                  <fpage>1967</fpage>
                  <lpage>1975</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.283.15.1967</pub-id>
                  <pub-id pub-id-type="pmid">10789664</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-genes-13-01260">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Arnett</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Boerwinkle</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Davis</surname>
                      <given-names>B.R.</given-names>
                    </name>
                    <name>
                      <surname>Eckfeldt</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ford</surname>
                      <given-names>C.E.</given-names>
                    </name>
                    <name>
                      <surname>Black</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Pharmacogenetic approaches to hypertension therapy: Design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study</article-title>
                  <source>Pharmacogenom. J.</source>
                  <year>2002</year>
                  <volume>2</volume>
                  <fpage>309</fpage>
                  <lpage>317</lpage>
                  <pub-id pub-id-type="doi">10.1038/sj.tpj.6500113</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-genes-13-01260">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Price</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Patterson</surname>
                      <given-names>N.J.</given-names>
                    </name>
                    <name>
                      <surname>Plenge</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Weinblatt</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>Shadick</surname>
                      <given-names>N.A.</given-names>
                    </name>
                    <name>
                      <surname>Reich</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Principal components analysis corrects for stratification in genome-wide association studies</article-title>
                  <source>Nat. Genet.</source>
                  <year>2006</year>
                  <volume>38</volume>
                  <fpage>904</fpage>
                  <lpage>909</lpage>
                  <pub-id pub-id-type="doi">10.1038/ng1847</pub-id>
                  <pub-id pub-id-type="pmid">16862161</pub-id>
                </element-citation>
              </ref>
              <ref id="B26-genes-13-01260">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cushman</surname>
                      <given-names>W.C.</given-names>
                    </name>
                    <name>
                      <surname>Ford</surname>
                      <given-names>C.E.</given-names>
                    </name>
                    <name>
                      <surname>Einhorn</surname>
                      <given-names>P.T.</given-names>
                    </name>
                    <name>
                      <surname>Wright</surname>
                      <given-names>J.T.</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                    <name>
                      <surname>Preston</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Davis</surname>
                      <given-names>B.R.</given-names>
                    </name>
                    <name>
                      <surname>Basile</surname>
                      <given-names>J.N.</given-names>
                    </name>
                    <name>
                      <surname>Whelton</surname>
                      <given-names>P.K.</given-names>
                    </name>
                    <name>
                      <surname>Weiss</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Bastien</surname>
                      <given-names>A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)</article-title>
                  <source>J. Clin. Hypertens.</source>
                  <year>2008</year>
                  <volume>10</volume>
                  <fpage>751</fpage>
                  <lpage>760</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1751-7176.2008.00015.x</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-genes-13-01260">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Do</surname>
                      <given-names>A.N.</given-names>
                    </name>
                    <name>
                      <surname>Lynch</surname>
                      <given-names>A.I.</given-names>
                    </name>
                    <name>
                      <surname>Claas</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Boerwinkle</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Davis</surname>
                      <given-names>B.R.</given-names>
                    </name>
                    <name>
                      <surname>Ford</surname>
                      <given-names>C.E.</given-names>
                    </name>
                    <name>
                      <surname>Eckfeldt</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Tiwari</surname>
                      <given-names>H.K.</given-names>
                    </name>
                    <name>
                      <surname>Arnett</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Irvin</surname>
                      <given-names>M.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study</article-title>
                  <source>J. Hum. Hypertens.</source>
                  <year>2016</year>
                  <volume>30</volume>
                  <fpage>549</fpage>
                  <lpage>554</lpage>
                  <pub-id pub-id-type="doi">10.1038/jhh.2015.121</pub-id>
                  <pub-id pub-id-type="pmid">26791477</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-genes-13-01260">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davis</surname>
                      <given-names>B.R.</given-names>
                    </name>
                    <name>
                      <surname>Cutler</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Furberg</surname>
                      <given-names>C.D.</given-names>
                    </name>
                    <name>
                      <surname>Wright</surname>
                      <given-names>J.T.</given-names>
                    </name>
                    <name>
                      <surname>Farber</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Felicetta</surname>
                      <given-names>J.V.</given-names>
                    </name>
                    <name>
                      <surname>Stokes</surname>
                      <given-names>J.D.</given-names>
                    </name>
                    <collab>ALLHAT Collaborative Research Group</collab>
                  </person-group>
                  <article-title>Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: Further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial</article-title>
                  <source>Ann. Intern. Med.</source>
                  <year>2002</year>
                  <volume>137</volume>
                  <fpage>313</fpage>
                  <lpage>320</lpage>
                  <pub-id pub-id-type="pmid">12204014</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-genes-13-01260">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Irvin</surname>
                      <given-names>M.R.</given-names>
                    </name>
                    <name>
                      <surname>Lynch</surname>
                      <given-names>A.I.</given-names>
                    </name>
                    <name>
                      <surname>Kabagambe</surname>
                      <given-names>E.K.</given-names>
                    </name>
                    <name>
                      <surname>Tiwari</surname>
                      <given-names>H.K.</given-names>
                    </name>
                    <name>
                      <surname>Barzilay</surname>
                      <given-names>J.I.</given-names>
                    </name>
                    <name>
                      <surname>Eckfeldt</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Boerwinkle</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Davis</surname>
                      <given-names>B.R.</given-names>
                    </name>
                    <name>
                      <surname>Ford</surname>
                      <given-names>C.E.</given-names>
                    </name>
                    <name>
                      <surname>Arnett</surname>
                      <given-names>D.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study</article-title>
                  <source>J. Hypertens.</source>
                  <year>2010</year>
                  <volume>28</volume>
                  <fpage>2076</fpage>
                  <lpage>2083</lpage>
                  <pub-id pub-id-type="doi">10.1097/HJH.0b013e32833c7a4d</pub-id>
                  <pub-id pub-id-type="pmid">20577119</pub-id>
                </element-citation>
              </ref>
              <ref id="B30-genes-13-01260">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Das</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Forer</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Schonherr</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sidore</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Locke</surname>
                      <given-names>A.E.</given-names>
                    </name>
                    <name>
                      <surname>Kwong</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Vrieze</surname>
                      <given-names>S.I.</given-names>
                    </name>
                    <name>
                      <surname>Chew</surname>
                      <given-names>E.Y.</given-names>
                    </name>
                    <name>
                      <surname>Levy</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>McGue</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Next-generation genotype imputation service and methods</article-title>
                  <source>Nat. Genet.</source>
                  <year>2016</year>
                  <volume>48</volume>
                  <fpage>1284</fpage>
                  <lpage>1287</lpage>
                  <pub-id pub-id-type="doi">10.1038/ng.3656</pub-id>
                  <pub-id pub-id-type="pmid">27571263</pub-id>
                </element-citation>
              </ref>
              <ref id="B31-genes-13-01260">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fuchsberger</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Abecasis</surname>
                      <given-names>G.R.</given-names>
                    </name>
                    <name>
                      <surname>Hinds</surname>
                      <given-names>D.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>minimac2: Faster genotype imputation</article-title>
                  <source>Bioinformatics</source>
                  <year>2015</year>
                  <volume>31</volume>
                  <fpage>782</fpage>
                  <lpage>784</lpage>
                  <pub-id pub-id-type="doi">10.1093/bioinformatics/btu704</pub-id>
                  <pub-id pub-id-type="pmid">25338720</pub-id>
                </element-citation>
              </ref>
              <ref id="B32-genes-13-01260">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Taliun</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Harris</surname>
                      <given-names>D.N.</given-names>
                    </name>
                    <name>
                      <surname>Kessler</surname>
                      <given-names>M.D.</given-names>
                    </name>
                    <name>
                      <surname>Carlson</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Szpiech</surname>
                      <given-names>Z.A.</given-names>
                    </name>
                    <name>
                      <surname>Torres</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Taliun</surname>
                      <given-names>S.A.G.</given-names>
                    </name>
                    <name>
                      <surname>Corvelo</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Gogarten</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Kang</surname>
                      <given-names>H.M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program</article-title>
                  <source>Nature</source>
                  <year>2021</year>
                  <volume>590</volume>
                  <fpage>290</fpage>
                  <lpage>299</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41586-021-03205-y</pub-id>
                  <?supplied-pmid 33568819?>
                  <pub-id pub-id-type="pmid">33568819</pub-id>
                </element-citation>
              </ref>
              <ref id="B33-genes-13-01260">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chang</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Chow</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Tellier</surname>
                      <given-names>L.C.</given-names>
                    </name>
                    <name>
                      <surname>Vattikuti</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Purcell</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>J.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Second-generation PLINK: Rising to the challenge of larger and richer datasets</article-title>
                  <source>Gigascience</source>
                  <year>2015</year>
                  <volume>4</volume>
                  <fpage>7</fpage>
                  <pub-id pub-id-type="doi">10.1186/s13742-015-0047-8</pub-id>
                  <?supplied-pmid 25722852?>
                  <pub-id pub-id-type="pmid">25722852</pub-id>
                </element-citation>
              </ref>
              <ref id="B34-genes-13-01260">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McCaw</surname>
                      <given-names>Z.R.</given-names>
                    </name>
                    <name>
                      <surname>Lane</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Saxena</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Redline</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>X.</given-names>
                    </name>
                  </person-group>
                  <article-title>Operating characteristics of the rank-based inverse normal transformation for quantitative trait analysis in genome-wide association studies</article-title>
                  <source>Biometrics</source>
                  <year>2020</year>
                  <volume>76</volume>
                  <fpage>1262</fpage>
                  <lpage>1272</lpage>
                  <pub-id pub-id-type="doi">10.1111/biom.13214</pub-id>
                  <?supplied-pmid 31883270?>
                  <pub-id pub-id-type="pmid">31883270</pub-id>
                </element-citation>
              </ref>
              <ref id="B35-genes-13-01260">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pruim</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Welch</surname>
                      <given-names>R.P.</given-names>
                    </name>
                    <name>
                      <surname>Sanna</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Teslovich</surname>
                      <given-names>T.M.</given-names>
                    </name>
                    <name>
                      <surname>Chines</surname>
                      <given-names>P.S.</given-names>
                    </name>
                    <name>
                      <surname>Gliedt</surname>
                      <given-names>T.P.</given-names>
                    </name>
                    <name>
                      <surname>Boehnke</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Abecasis</surname>
                      <given-names>G.R.</given-names>
                    </name>
                    <name>
                      <surname>Willer</surname>
                      <given-names>C.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>LocusZoom: Regional visualization of genome-wide association scan results</article-title>
                  <source>Bioinformatics</source>
                  <year>2010</year>
                  <volume>26</volume>
                  <fpage>2336</fpage>
                  <lpage>2337</lpage>
                  <pub-id pub-id-type="doi">10.1093/bioinformatics/btq419</pub-id>
                  <?supplied-pmid 20634204?>
                  <pub-id pub-id-type="pmid">20634204</pub-id>
                </element-citation>
              </ref>
              <ref id="B36-genes-13-01260">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boughton</surname>
                      <given-names>A.P.</given-names>
                    </name>
                    <name>
                      <surname>Welch</surname>
                      <given-names>R.P.</given-names>
                    </name>
                    <name>
                      <surname>Flickinger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>VandeHaar</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Taliun</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Abecasis</surname>
                      <given-names>G.R.</given-names>
                    </name>
                    <name>
                      <surname>Boehnke</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>LocusZoom.js: Interactive and embeddable visualization of genetic association study results</article-title>
                  <source>Bioinformatics</source>
                  <year>2021</year>
                  <volume>37</volume>
                  <fpage>3017</fpage>
                  <lpage>3018</lpage>
                  <pub-id pub-id-type="doi">10.1093/bioinformatics/btab186</pub-id>
                  <?supplied-pmid 33734315?>
                  <pub-id pub-id-type="pmid">33734315</pub-id>
                </element-citation>
              </ref>
              <ref id="B37-genes-13-01260">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hakonarson</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data</article-title>
                  <source>Nucleic Acids Res.</source>
                  <year>2010</year>
                  <volume>38</volume>
                  <fpage>e164</fpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id>
                  <?supplied-pmid 20601685?>
                  <pub-id pub-id-type="pmid">20601685</pub-id>
                </element-citation>
              </ref>
              <ref id="B38-genes-13-01260">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chapman</surname>
                      <given-names>A.B.</given-names>
                    </name>
                    <name>
                      <surname>Schwartz</surname>
                      <given-names>G.L.</given-names>
                    </name>
                    <name>
                      <surname>Boerwinkle</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Turner</surname>
                      <given-names>S.T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension</article-title>
                  <source>Kidney Int.</source>
                  <year>2002</year>
                  <volume>61</volume>
                  <fpage>1047</fpage>
                  <lpage>1055</lpage>
                  <pub-id pub-id-type="doi">10.1046/j.1523-1755.2002.00200.x</pub-id>
                  <pub-id pub-id-type="pmid">11849460</pub-id>
                </element-citation>
              </ref>
              <ref id="B39-genes-13-01260">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Johnson</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Boerwinkle</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Zineh</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Chapman</surname>
                      <given-names>A.B.</given-names>
                    </name>
                    <name>
                      <surname>Bailey</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Cooper-DeHoff</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Gums</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Curry</surname>
                      <given-names>R.W.</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Beitelshees</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study</article-title>
                  <source>Am. Heart J.</source>
                  <year>2009</year>
                  <volume>157</volume>
                  <fpage>442</fpage>
                  <lpage>449</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ahj.2008.11.018</pub-id>
                  <pub-id pub-id-type="pmid">19249413</pub-id>
                </element-citation>
              </ref>
              <ref id="B40-genes-13-01260">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hamadeh</surname>
                      <given-names>I.S.</given-names>
                    </name>
                    <name>
                      <surname>Langaee</surname>
                      <given-names>T.Y.</given-names>
                    </name>
                    <name>
                      <surname>Dwivedi</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Garcia</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Burkley</surname>
                      <given-names>B.M.</given-names>
                    </name>
                    <name>
                      <surname>Skaar</surname>
                      <given-names>T.C.</given-names>
                    </name>
                    <name>
                      <surname>Chapman</surname>
                      <given-names>A.B.</given-names>
                    </name>
                    <name>
                      <surname>Gums</surname>
                      <given-names>J.G.</given-names>
                    </name>
                    <name>
                      <surname>Turner</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate</article-title>
                  <source>Clin. Pharmacol. Ther.</source>
                  <year>2014</year>
                  <volume>96</volume>
                  <fpage>175</fpage>
                  <lpage>181</lpage>
                  <pub-id pub-id-type="doi">10.1038/clpt.2014.62</pub-id>
                  <pub-id pub-id-type="pmid">24637943</pub-id>
                </element-citation>
              </ref>
              <ref id="B41-genes-13-01260">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sa</surname>
                      <given-names>A.C.C.</given-names>
                    </name>
                    <name>
                      <surname>Webb</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>McDonough</surname>
                      <given-names>C.W.</given-names>
                    </name>
                    <name>
                      <surname>Shahin</surname>
                      <given-names>M.H.</given-names>
                    </name>
                    <name>
                      <surname>Datta</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Langaee</surname>
                      <given-names>T.Y.</given-names>
                    </name>
                    <name>
                      <surname>Turner</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <name>
                      <surname>Beitelshees</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Chapman</surname>
                      <given-names>A.B.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Blood pressure signature genes and blood pressure response to thiazide diuretics: Results from the PEAR and PEAR-2 studies</article-title>
                  <source>BMC Med. Genom.</source>
                  <year>2018</year>
                  <volume>11</volume>
                  <elocation-id>55</elocation-id>
                  <pub-id pub-id-type="doi">10.1186/s12920-018-0370-x</pub-id>
                </element-citation>
              </ref>
              <ref id="B42-genes-13-01260">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McDonough</surname>
                      <given-names>C.W.</given-names>
                    </name>
                    <name>
                      <surname>Warren</surname>
                      <given-names>H.R.</given-names>
                    </name>
                    <name>
                      <surname>Jack</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Motsinger-Reif</surname>
                      <given-names>A.A.</given-names>
                    </name>
                    <name>
                      <surname>Armstrong</surname>
                      <given-names>N.D.</given-names>
                    </name>
                    <name>
                      <surname>Bis</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>House</surname>
                      <given-names>J.S.</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Rouby</surname>
                      <given-names>N.M.E.</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies</article-title>
                  <source>Clin. Pharmacol. Ther.</source>
                  <year>2021</year>
                  <volume>110</volume>
                  <fpage>723</fpage>
                  <lpage>732</lpage>
                  <pub-id pub-id-type="doi">10.1002/cpt.2355</pub-id>
                  <pub-id pub-id-type="pmid">34231218</pub-id>
                </element-citation>
              </ref>
              <ref id="B43-genes-13-01260">
                <label>43.</label>
                <element-citation publication-type="gov">
                  <person-group person-group-type="author">
                    <collab>National Library of Medicine, National Center for Biotechnology Information</collab>
                  </person-group>
                  <article-title>Gene</article-title>
                  <comment>Available online: <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/gene/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/gene/</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2022-01-27">(accessed on 27 January 2022)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B44-genes-13-01260">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wojczynski</surname>
                      <given-names>M.K.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bielak</surname>
                      <given-names>L.F.</given-names>
                    </name>
                    <name>
                      <surname>Kerr</surname>
                      <given-names>K.F.</given-names>
                    </name>
                    <name>
                      <surname>Reiner</surname>
                      <given-names>A.P.</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>N.D.</given-names>
                    </name>
                    <name>
                      <surname>Yanek</surname>
                      <given-names>L.R.</given-names>
                    </name>
                    <name>
                      <surname>Qu</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>White</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Lange</surname>
                      <given-names>L.A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genetics of coronary artery calcification among African Americans, a meta-analysis</article-title>
                  <source>BMC Med. Genet.</source>
                  <year>2013</year>
                  <volume>14</volume>
                  <elocation-id>75</elocation-id>
                  <pub-id pub-id-type="doi">10.1186/1471-2350-14-75</pub-id>
                  <pub-id pub-id-type="pmid">23870195</pub-id>
                </element-citation>
              </ref>
              <ref id="B45-genes-13-01260">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Motro</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Shemesh</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics</article-title>
                  <source>Hypertension</source>
                  <year>2001</year>
                  <volume>37</volume>
                  <fpage>1410</fpage>
                  <lpage>1413</lpage>
                  <pub-id pub-id-type="doi">10.1161/01.HYP.37.6.1410</pub-id>
                  <pub-id pub-id-type="pmid">11408386</pub-id>
                </element-citation>
              </ref>
              <ref id="B46-genes-13-01260">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Strutz</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Zeisberg</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Renal fibroblasts and myofibroblasts in chronic kidney disease</article-title>
                  <source>J. Am. Soc. Nephrol.</source>
                  <year>2006</year>
                  <volume>17</volume>
                  <fpage>2992</fpage>
                  <lpage>2998</lpage>
                  <pub-id pub-id-type="doi">10.1681/ASN.2006050420</pub-id>
                  <pub-id pub-id-type="pmid">17035610</pub-id>
                </element-citation>
              </ref>
              <ref id="B47-genes-13-01260">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thedieck</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Kalbacher</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Kuczyk</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Muller</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Muller</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Klein</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cadherin-9 is a novel cell surface marker for the heterogeneous pool of renal fibroblasts</article-title>
                  <source>PLoS ONE</source>
                  <year>2007</year>
                  <volume>2</volume>
                  <elocation-id>e657</elocation-id>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0000657</pub-id>
                  <pub-id pub-id-type="pmid">17668045</pub-id>
                </element-citation>
              </ref>
              <ref id="B48-genes-13-01260">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Krapf</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Hulter</surname>
                      <given-names>H.N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA)</article-title>
                  <source>Clin. J. Am. Soc. Nephrol.</source>
                  <year>2009</year>
                  <volume>4</volume>
                  <fpage>470</fpage>
                  <lpage>480</lpage>
                  <pub-id pub-id-type="doi">10.2215/CJN.05040908</pub-id>
                  <pub-id pub-id-type="pmid">19218474</pub-id>
                </element-citation>
              </ref>
              <ref id="B49-genes-13-01260">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cheng</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Asuncion-Chin</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Blaskova</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Bannister</surname>
                      <given-names>J.P.</given-names>
                    </name>
                    <name>
                      <surname>Dopico</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Jaggar</surname>
                      <given-names>J.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>A novel Ca<sub>V</sub>1.2 N terminus expressed in smooth muscle cells of resistance size arteries modifies channel regulation by auxiliary subunits</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2007</year>
                  <volume>282</volume>
                  <fpage>29211</fpage>
                  <lpage>29221</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M610623200</pub-id>
                  <pub-id pub-id-type="pmid">17699517</pub-id>
                </element-citation>
              </ref>
              <ref id="B50-genes-13-01260">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cox</surname>
                      <given-names>R.H.</given-names>
                    </name>
                    <name>
                      <surname>Rusch</surname>
                      <given-names>N.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure</article-title>
                  <source>Microcirculation</source>
                  <year>2002</year>
                  <volume>9</volume>
                  <fpage>243</fpage>
                  <lpage>257</lpage>
                  <pub-id pub-id-type="doi">10.1080/mic.9.4.243.257</pub-id>
                  <pub-id pub-id-type="pmid">12152102</pub-id>
                </element-citation>
              </ref>
              <ref id="B51-genes-13-01260">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bremer</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Man</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Kask</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Diamond</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension</article-title>
                  <source>Pharmacogenomics</source>
                  <year>2006</year>
                  <volume>7</volume>
                  <fpage>271</fpage>
                  <lpage>279</lpage>
                  <pub-id pub-id-type="doi">10.2217/14622416.7.3.271</pub-id>
                  <pub-id pub-id-type="pmid">16610939</pub-id>
                </element-citation>
              </ref>
              <ref id="B52-genes-13-01260">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kamide</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Matayoshi</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Takiuchi</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Horio</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Yoshii</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Miwa</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Yasuda</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Yoshihara</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Nakamura</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genetic polymorphisms of L-type calcium channel α1C and α1D subunit genes are associated with sensitivity to the antihypertensive effects of L-type dihydropyridine calcium-channel blockers</article-title>
                  <source>Circ. J.</source>
                  <year>2009</year>
                  <volume>73</volume>
                  <fpage>732</fpage>
                  <lpage>740</lpage>
                  <pub-id pub-id-type="doi">10.1253/circj.CJ-08-0761</pub-id>
                  <pub-id pub-id-type="pmid">19225208</pub-id>
                </element-citation>
              </ref>
              <ref id="B53-genes-13-01260">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Beitelshees</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Navare</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Wessel</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Moss</surname>
                      <given-names>J.I.</given-names>
                    </name>
                    <name>
                      <surname>Langaee</surname>
                      <given-names>T.Y.</given-names>
                    </name>
                    <name>
                      <surname>Cooper-DeHoff</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Sadee</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Pepine</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response</article-title>
                  <source>Circ. Cardiovasc. Genet.</source>
                  <year>2009</year>
                  <volume>2</volume>
                  <fpage>362</fpage>
                  <lpage>370</lpage>
                  <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.109.857839</pub-id>
                  <pub-id pub-id-type="pmid">20031608</pub-id>
                </element-citation>
              </ref>
              <ref id="B54-genes-13-01260">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hu</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>He</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Rao</surname>
                      <given-names>D.C.</given-names>
                    </name>
                    <name>
                      <surname>Hixson</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Gu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Kelly</surname>
                      <given-names>T.N.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Associations of Variants in the CACNA1A and CACNA1C Genes with Longitudinal Blood Pressure Changes and Hypertension Incidence: The GenSalt Study</article-title>
                  <source>Am. J. Hypertens.</source>
                  <year>2016</year>
                  <volume>29</volume>
                  <fpage>1301</fpage>
                  <lpage>1306</lpage>
                  <pub-id pub-id-type="doi">10.1093/ajh/hpw070</pub-id>
                  <pub-id pub-id-type="pmid">27418245</pub-id>
                </element-citation>
              </ref>
              <ref id="B55-genes-13-01260">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wain</surname>
                      <given-names>L.V.</given-names>
                    </name>
                    <name>
                      <surname>Verwoert</surname>
                      <given-names>G.C.</given-names>
                    </name>
                    <name>
                      <surname>O’Reilly</surname>
                      <given-names>P.F.</given-names>
                    </name>
                    <name>
                      <surname>Shi</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>A.D.</given-names>
                    </name>
                    <name>
                      <surname>Bochud</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Rice</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Henneman</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>A.V.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure</article-title>
                  <source>Nat. Genet.</source>
                  <year>2011</year>
                  <volume>43</volume>
                  <fpage>1005</fpage>
                  <lpage>1011</lpage>
                  <pub-id pub-id-type="doi">10.1038/ng.922</pub-id>
                  <pub-id pub-id-type="pmid">21909110</pub-id>
                </element-citation>
              </ref>
              <ref id="B56-genes-13-01260">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sumida</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Naito</surname>
                      <given-names>A.T.</given-names>
                    </name>
                    <name>
                      <surname>Nomura</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Nakagawa</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Higo</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Hashimoto</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Okada</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Sakai</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Ito</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Yamaguchi</surname>
                      <given-names>T.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Complement C1q-induced activation of beta-catenin signalling causes hypertensive arterial remodelling</article-title>
                  <source>Nat. Commun.</source>
                  <year>2015</year>
                  <volume>6</volume>
                  <fpage>6241</fpage>
                  <pub-id pub-id-type="doi">10.1038/ncomms7241</pub-id>
                  <pub-id pub-id-type="pmid">25716000</pub-id>
                </element-citation>
              </ref>
              <ref id="B57-genes-13-01260">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Abou Ziki</surname>
                      <given-names>M.D.</given-names>
                    </name>
                    <name>
                      <surname>Mani</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Wnt signaling, a novel pathway regulating blood pressure? State of the art review</article-title>
                  <source>Atherosclerosis</source>
                  <year>2017</year>
                  <volume>262</volume>
                  <fpage>171</fpage>
                  <lpage>178</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2017.05.001</pub-id>
                  <pub-id pub-id-type="pmid">28522145</pub-id>
                </element-citation>
              </ref>
              <ref id="B58-genes-13-01260">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Van de Schans</surname>
                      <given-names>V.A.</given-names>
                    </name>
                    <name>
                      <surname>van den Borne</surname>
                      <given-names>S.W.</given-names>
                    </name>
                    <name>
                      <surname>Strzelecka</surname>
                      <given-names>A.E.</given-names>
                    </name>
                    <name>
                      <surname>Janssen</surname>
                      <given-names>B.J.</given-names>
                    </name>
                    <name>
                      <surname>van der Velden</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Langen</surname>
                      <given-names>R.C.</given-names>
                    </name>
                    <name>
                      <surname>Wynshaw-Boris</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Smits</surname>
                      <given-names>J.F.M.</given-names>
                    </name>
                    <name>
                      <surname>Blankesteijn</surname>
                      <given-names>W.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy</article-title>
                  <source>Hypertension</source>
                  <year>2007</year>
                  <volume>49</volume>
                  <fpage>473</fpage>
                  <lpage>480</lpage>
                  <pub-id pub-id-type="doi">10.1161/01.HYP.0000255946.55091.24</pub-id>
                  <pub-id pub-id-type="pmid">17210832</pub-id>
                </element-citation>
              </ref>
              <ref id="B59-genes-13-01260">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jones</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Zavadzkas</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>E.I.</given-names>
                    </name>
                    <name>
                      <surname>Sheats</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Koval</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Stroud</surname>
                      <given-names>R.E.</given-names>
                    </name>
                    <name>
                      <surname>Spinale</surname>
                      <given-names>F.G.</given-names>
                    </name>
                    <name>
                      <surname>Ikonomidis</surname>
                      <given-names>J.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cellular phenotype transformation occurs during thoracic aortic aneurysm development</article-title>
                  <source>J. Thorac. Cardiovasc. Surg.</source>
                  <year>2010</year>
                  <volume>140</volume>
                  <fpage>653</fpage>
                  <lpage>659</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jtcvs.2009.12.033</pub-id>
                  <pub-id pub-id-type="pmid">20219212</pub-id>
                </element-citation>
              </ref>
              <ref id="B60-genes-13-01260">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oklu</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Hesketh</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>The latent transforming growth factor beta binding protein (LTBP) family</article-title>
                  <source>Biochem. J.</source>
                  <year>2000</year>
                  <volume>352</volume>
                  <fpage>601</fpage>
                  <lpage>610</lpage>
                  <pub-id pub-id-type="doi">10.1042/bj3520601</pub-id>
                  <pub-id pub-id-type="pmid">11104663</pub-id>
                </element-citation>
              </ref>
              <ref id="B61-genes-13-01260">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bao</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Tan</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genome Wide Association Study Identifies L3MBTL4 as a Novel Susceptibility Gene for Hypertension</article-title>
                  <source>Sci. Rep.</source>
                  <year>2016</year>
                  <volume>6</volume>
                  <fpage>30811</fpage>
                  <pub-id pub-id-type="doi">10.1038/srep30811</pub-id>
                  <pub-id pub-id-type="pmid">27480026</pub-id>
                </element-citation>
              </ref>
              <ref id="B62-genes-13-01260">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hui</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Smalera</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Jian</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Goldhahn</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Fitzgerald</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Funk</surname>
                      <given-names>C.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure</article-title>
                  <source>Circulation</source>
                  <year>2004</year>
                  <volume>110</volume>
                  <fpage>3360</fpage>
                  <lpage>3366</lpage>
                  <pub-id pub-id-type="doi">10.1161/01.CIR.0000147775.50954.AA</pub-id>
                  <pub-id pub-id-type="pmid">15545522</pub-id>
                </element-citation>
              </ref>
              <ref id="B63-genes-13-01260">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Murphy</surname>
                      <given-names>R.C.</given-names>
                    </name>
                    <name>
                      <surname>Hammarstrom</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Samuelsson</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Leukotriene C: A slow-reacting substance from murine mastocytoma cells</article-title>
                  <source>Proc. Natl. Acad. Sci. USA</source>
                  <year>1979</year>
                  <volume>76</volume>
                  <fpage>4275</fpage>
                  <lpage>4279</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.76.9.4275</pub-id>
                  <?supplied-pmid 41240?>
                  <pub-id pub-id-type="pmid">41240</pub-id>
                </element-citation>
              </ref>
              <ref id="B64-genes-13-01260">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Samuelsson</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation</article-title>
                  <source>Science</source>
                  <year>1983</year>
                  <volume>220</volume>
                  <fpage>568</fpage>
                  <lpage>575</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.6301011</pub-id>
                  <?supplied-pmid 6301011?>
                  <pub-id pub-id-type="pmid">6301011</pub-id>
                </element-citation>
              </ref>
              <ref id="B65-genes-13-01260">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heinonen</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Laine</surname>
                      <given-names>A.P.</given-names>
                    </name>
                    <name>
                      <surname>Soderhall</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Gruzieva</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Rautio</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Melen</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Pershagen</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Lähdesmäki</surname>
                      <given-names>H.J.</given-names>
                    </name>
                    <name>
                      <surname>Knip</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ilonen</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>GIMAP GTPase family genes: Potential modifiers in autoimmune diabetes, asthma, and allergy</article-title>
                  <source>J. Immunol.</source>
                  <year>2015</year>
                  <volume>194</volume>
                  <fpage>5885</fpage>
                  <lpage>5894</lpage>
                  <pub-id pub-id-type="doi">10.4049/jimmunol.1500016</pub-id>
                  <?supplied-pmid 25964488?>
                  <pub-id pub-id-type="pmid">25964488</pub-id>
                </element-citation>
              </ref>
              <ref id="B66-genes-13-01260">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Divers</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Palmer</surname>
                      <given-names>N.D.</given-names>
                    </name>
                    <name>
                      <surname>Langefeld</surname>
                      <given-names>C.D.</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>W.M.</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Hicks</surname>
                      <given-names>P.J.</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Terry</surname>
                      <given-names>J.G.</given-names>
                    </name>
                    <name>
                      <surname>Register</surname>
                      <given-names>T.C.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genome-wide association study of coronary artery calcified atherosclerotic plaque in African Americans with type 2 diabetes</article-title>
                  <source>BMC Genet.</source>
                  <year>2017</year>
                  <volume>18</volume>
                  <elocation-id>105</elocation-id>
                  <pub-id pub-id-type="doi">10.1186/s12863-017-0572-9</pub-id>
                  <pub-id pub-id-type="pmid">29221444</pub-id>
                </element-citation>
              </ref>
              <ref id="B67-genes-13-01260">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Qi</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Gan</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Loos</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>X.</given-names>
                    </name>
                  </person-group>
                  <article-title>Common variants in or near FGF5, CYP17A1 and MTHFR genes are associated with blood pressure and hypertension in Chinese Hans</article-title>
                  <source>J. Hypertens.</source>
                  <year>2011</year>
                  <volume>29</volume>
                  <fpage>70</fpage>
                  <lpage>75</lpage>
                  <pub-id pub-id-type="doi">10.1097/HJH.0b013e32833f60ab</pub-id>
                  <pub-id pub-id-type="pmid">20852445</pub-id>
                </element-citation>
              </ref>
              <ref id="B68-genes-13-01260">
                <label>68.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ren</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Jiao</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Expression level of fibroblast growth factor 5 (FGF5) in the peripheral blood of primary hypertension and its clinical significance</article-title>
                  <source>Saudi J. Biol. Sci.</source>
                  <year>2018</year>
                  <volume>25</volume>
                  <fpage>469</fpage>
                  <lpage>473</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.sjbs.2017.11.043</pub-id>
                  <pub-id pub-id-type="pmid">29692649</pub-id>
                </element-citation>
              </ref>
              <ref id="B69-genes-13-01260">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chittani</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Zaninello</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Lanzani</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Frau</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Ortu</surname>
                      <given-names>M.F.</given-names>
                    </name>
                    <name>
                      <surname>Salvi</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Fresu</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Citterio</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Braga</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Piras</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives</article-title>
                  <source>J. Hypertens.</source>
                  <year>2015</year>
                  <volume>33</volume>
                  <fpage>1301</fpage>
                  <lpage>1309</lpage>
                  <pub-id pub-id-type="doi">10.1097/HJH.0000000000000541</pub-id>
                  <pub-id pub-id-type="pmid">25695618</pub-id>
                </element-citation>
              </ref>
              <ref id="B70-genes-13-01260">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hiltunen</surname>
                      <given-names>T.P.</given-names>
                    </name>
                    <name>
                      <surname>Donner</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Sarin</surname>
                      <given-names>A.P.</given-names>
                    </name>
                    <name>
                      <surname>Saarela</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ripatti</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Chapman</surname>
                      <given-names>A.B.</given-names>
                    </name>
                    <name>
                      <surname>Gums</surname>
                      <given-names>J.G.</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Cooper-DeHoff</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Frau</surname>
                      <given-names>F.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Pharmacogenomics of hypertension: A genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs</article-title>
                  <source>J. Am. Heart Assoc.</source>
                  <year>2015</year>
                  <volume>4</volume>
                  <fpage>e001521</fpage>
                  <pub-id pub-id-type="doi">10.1161/JAHA.114.001521</pub-id>
                  <pub-id pub-id-type="pmid">25622599</pub-id>
                </element-citation>
              </ref>
              <ref id="B71-genes-13-01260">
                <label>71.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wegner</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Al-Momany</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Kulak</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Kozlowski</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Obeidat</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Jahroudi</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Paes</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Berryman</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ballerman</surname>
                      <given-names>B.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>CLIC5A, a component of the ezrin-podocalyxin complex in glomeruli, is a determinant of podocyte integrity</article-title>
                  <source>Am. J. Physiol. Renal Physiol.</source>
                  <year>2010</year>
                  <volume>298</volume>
                  <fpage>F1492</fpage>
                  <lpage>F1503</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajprenal.00030.2010</pub-id>
                  <pub-id pub-id-type="pmid">20335315</pub-id>
                </element-citation>
              </ref>
              <ref id="B72-genes-13-01260">
                <label>72.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ying</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Peng</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>EBF1 gene polymorphism and its interaction with smoking and drinking on the risk of coronary artery disease for Chinese patients</article-title>
                  <source>Biosci. Rep.</source>
                  <year>2018</year>
                  <volume>38</volume>
                  <fpage>BSR20180324</fpage>
                  <pub-id pub-id-type="doi">10.1042/BSR20180324</pub-id>
                  <pub-id pub-id-type="pmid">29789399</pub-id>
                </element-citation>
              </ref>
              <ref id="B73-genes-13-01260">
                <label>73.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Evangelou</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Warren</surname>
                      <given-names>H.R.</given-names>
                    </name>
                    <name>
                      <surname>Mosen-Ansorena</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Mifsud</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Pazoki</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Nitritsos</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Dimou</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Cabrera</surname>
                      <given-names>C.P.</given-names>
                    </name>
                    <name>
                      <surname>Karaman</surname>
                      <given-names>I.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits</article-title>
                  <source>Nat. Genet.</source>
                  <year>2018</year>
                  <volume>50</volume>
                  <fpage>1412</fpage>
                  <lpage>1425</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41588-018-0205-x</pub-id>
                  <pub-id pub-id-type="pmid">30224653</pub-id>
                </element-citation>
              </ref>
              <ref id="B74-genes-13-01260">
                <label>74.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Singh</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>McDonough</surname>
                      <given-names>C.W.</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Alghamdi</surname>
                      <given-names>W.A.</given-names>
                    </name>
                    <name>
                      <surname>Arwood</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Bargal</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Dumeny</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>W.-Y.</given-names>
                    </name>
                    <name>
                      <surname>Mehanna</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Stockard</surname>
                      <given-names>B.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients</article-title>
                  <source>J. Am. Heart Assoc.</source>
                  <year>2018</year>
                  <volume>7</volume>
                  <fpage>e007339</fpage>
                  <pub-id pub-id-type="doi">10.1161/JAHA.117.007339</pub-id>
                  <pub-id pub-id-type="pmid">29523524</pub-id>
                </element-citation>
              </ref>
              <ref id="B75-genes-13-01260">
                <label>75.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Singh</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>McDonough</surname>
                      <given-names>C.W.</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Bailey</surname>
                      <given-names>K.R.</given-names>
                    </name>
                    <name>
                      <surname>Boerwinkle</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Chapman</surname>
                      <given-names>A.B.</given-names>
                    </name>
                    <name>
                      <surname>Gums</surname>
                      <given-names>J.G.</given-names>
                    </name>
                    <name>
                      <surname>Turner</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <name>
                      <surname>Cooper-DeHoff</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>J.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response</article-title>
                  <source>Sci. Rep.</source>
                  <year>2019</year>
                  <volume>9</volume>
                  <fpage>17323</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-019-53345-5</pub-id>
                  <pub-id pub-id-type="pmid">31754133</pub-id>
                </element-citation>
              </ref>
              <ref id="B76-genes-13-01260">
                <label>76.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Singh</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Shahin</surname>
                      <given-names>M.H.</given-names>
                    </name>
                    <name>
                      <surname>Langaee</surname>
                      <given-names>T.Y.</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Turner</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <name>
                      <surname>Chapman</surname>
                      <given-names>A.B.</given-names>
                    </name>
                    <name>
                      <surname>Gums</surname>
                      <given-names>J.G.</given-names>
                    </name>
                    <name>
                      <surname>McDonough</surname>
                      <given-names>C.W.</given-names>
                    </name>
                    <name>
                      <surname>Bailey</surname>
                      <given-names>K.R.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide</article-title>
                  <source>Pharmacogenet. Genom.</source>
                  <year>2018</year>
                  <volume>28</volume>
                  <fpage>251</fpage>
                  <lpage>255</lpage>
                  <pub-id pub-id-type="doi">10.1097/FPC.0000000000000353</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig position="float" id="genes-13-01260-f001">
              <label>Figure 1</label>
              <caption>
                <p>Manhattan plots for the primary discovery analyses for BP response. The red line is representative of genome-wide significance (<italic toggle="yes">p</italic> &lt; 5.00 × 10<sup>−8</sup>). Results are shown from (<bold>a</bold>) ΔSBP analysis; (<bold>b</bold>) ΔDBP analysis.</p>
              </caption>
              <graphic xlink:href="genes-13-01260-g001" position="float"/>
            </fig>
            <fig position="float" id="genes-13-01260-f002">
              <label>Figure 2</label>
              <caption>
                <p>Manhattan plots for the treatment-naïve (T-N) analyses. The red line is representative of genome-wide significance (<italic toggle="yes">p</italic> &lt; 5.00 × 10<sup>−8</sup>). Results are shown from: (<bold>a</bold>) ΔSBP<sub>T-N</sub> analysis; (<bold>b</bold>) ΔDBP<sub>T-N</sub> analysis.</p>
              </caption>
              <graphic xlink:href="genes-13-01260-g002" position="float"/>
            </fig>
            <table-wrap position="float" id="genes-13-01260-t001">
              <object-id pub-id-type="pii">geosciences-993288-t001_Table 1</object-id>
              <label>Table 1</label>
              <caption>
                <p>Baseline GenHAT chlorthalidone participant demographics <sup>1</sup>.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">4297</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Sex, % Female</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">55.71% (2394)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Age, years</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">66.14 ± 7.73</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">30.46 ± 6.54</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T2D status</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">40.66% (1747)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Cigarette smoking status</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">27.44% (1000)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">eGFR, mL/min/1.73 m<sup>2</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">82.66 ± 21.49</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SBP, mmHg</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">146.14 ± 15.67</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">DBP, mmHg</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">84.86 ± 21.49</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">FG, mg/dL</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">127.40 ± 65.30</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K, mmol/L</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.22 ± 0.54</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p><sup>1</sup> Abbreviations: BMI—body mass index; T2D—type 2 diabetes mellitus; eGFR—estimated glomerular filtration rate; SBP—systolic blood pressure; DBP—diastolic blood pressure; FG—fasting glucose; K—serum potassium.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="genes-13-01260-t002">
              <object-id pub-id-type="pii">genes-13-01260-t002_Table 2</object-id>
              <label>Table 2</label>
              <caption>
                <p>Chlorthalidone blood pressure and glucose response <sup>1</sup>.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mean Difference ± SD</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">ΔSBP, mmHg</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3982</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−6.69 ± 19.30</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">ΔDBP, mmHg</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3982</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−3.06 ± 10.82</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ΔFG, mg/dL</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1127</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.71 ± 58.65</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p><sup>1</sup> Abbreviations: SD—standard deviation; SBP—systolic blood pressure; DBP—diastolic blood pressure; FG—fasting glucose.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="genes-13-01260-t003">
              <object-id pub-id-type="pii">genes-13-01260-t003_Table 3</object-id>
              <label>Table 3</label>
              <caption>
                <p>Top variants associated with blood pressure response to chlorthalidone use over six months (<italic toggle="yes">p</italic> &lt; 1.00 × 10<sup>−7</sup>) <sup>1</sup>.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">rsID</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CHR:BP</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">A1/A2</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EAF</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">β <sup>2</sup></th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic toggle="yes">p</italic>
                      <sup>3</sup>
                    </th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Location</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th>
                  </tr>
                  <tr>
                    <th align="center" valign="middle" rowspan="1" colspan="1">ΔSBP</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">
</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>rs191702725</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>5:176580424</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>A/G</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.003</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>1.08</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.73, 1.43</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>2.40 × 10<sup>−9</sup></bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>intronic</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>
                        <italic toggle="yes">CDHR2</italic>
                      </bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>rs6009272</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>22:49475763</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>G/C</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.444</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.11</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.07, 0.15</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>2.14 × 10<sup>−8</sup></bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>intergenic</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>
                        <italic toggle="yes">LINC01310; MIR3667</italic>
                      </bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>rs186198403</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>5:176649236</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>A/G</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.003</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>1.02</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.66, 1.39</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>3.15 × 10<sup>−8</sup></bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>intronic</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>
                        <italic toggle="yes">TSPAN17</italic>
                      </bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>ΔDBP</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>rs10440665</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>5:25918567</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>G/A</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.267</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>−0.11</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>−0.15, −0.07</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>4.48 × 10<sup>−8</sup></bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>intergenic</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>
                        <italic toggle="yes">LINC02211; CDH9</italic>
                      </bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">rs1593983</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5:25919837</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A/G</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.267</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.11</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.15, −0.07</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5.18 × 10<sup>−8</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">intergenic</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">LINC02211; CDH9</italic>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">rs28413118</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5:25929421</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A/C</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.270</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.11</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.15, −0.07</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5.37 × 10<sup>−8</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">intergenic</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">LINC02211; CDH9</italic>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">rs10050387</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5:25928779</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C/T</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.268</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.11</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.15, −0.07</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5.44 × 10<sup>−8</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">intergenic</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">LINC02211; CDH9</italic>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">rs4701513</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5:25925888</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T/A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.268</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.11</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.15, −0.07</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5.44 × 10<sup>−8</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">intergenic</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">LINC02211; CDH9</italic>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">rs10440666</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5:25918597</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">G/A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.267</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.11</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.15, −0.07</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">6.47 × 10<sup>−8</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">intergenic</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">LINC02211; CDH9</italic>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">rs12697671</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5:25929723</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A/C</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.268</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.11</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.15, −0.07</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">6.61 × 10<sup>−8</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">intergenic</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">LINC02211; CDH9</italic>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">rs72748996</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5:25924670</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">G/A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.268</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.11</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.15, −0.07</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.83 × 10<sup>−8</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">intergenic</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">LINC02211; CDH9</italic>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">rs13164498</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5:25931554</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T/A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.275</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.11</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.15, −0.07</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.98 × 10<sup>−8</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">intergenic</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">LINC02211; CDH9</italic>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">rs6884731</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5:25921084</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">G/A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.268</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.11</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.15, −0.07</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">8.72 × 10<sup>−8</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">intergenic</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">LINC02211; CDH9</italic>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs10440667</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5:25919034</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G/A</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.267</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.11</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.15, −0.07</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.58 × 10<sup>−8</sup></td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">intergenic</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic toggle="yes">LINC02211; CDH9</italic>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p><sup>1</sup> Abbreviations: rsID—reference snp cluster id; CHR—chromosome number; BP—base position from hg38 build; A1—effect allele; A2—allele 2; EAF—effect allele frequency; CI—confidence interval; SBP—systolic blood pressure; DBP—diastolic blood pressure. <sup>2</sup> Associations are presented as standardized coefficients from additive genetic linear models. <sup>3</sup> Genome-wide significance <italic toggle="yes">p</italic> &lt; 5.00 × 10<sup>−8</sup> (<bold>bold</bold>).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="genes-13-01260-t004">
              <object-id pub-id-type="pii">genes-13-01260-t004_Table 4</object-id>
              <label>Table 4</label>
              <caption>
                <p>Top variants associated with systolic blood pressure response to chlorthalidone use over six months in treatment-naïve participants (<italic toggle="yes">p</italic> &lt; 1.00 × 10<sup>−7</sup>) <sup>1</sup>.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">rsID</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CHR:BP</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">A1/A2</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EAF</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">β <sup>2</sup></th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> <sup>3</sup></th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Location</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>rs114758661</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>12:2472136</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>G/A</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.017</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>1.26</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.84, 1.68</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>1.12 × 10<sup>−8</sup></bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>intronic</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>
                        <italic toggle="yes">CACNA1C</italic>
                      </bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>rs540857940</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>12:2475156</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>A/G</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.017</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>1.26</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.84, 1.68</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>1.12 × 10<sup>−8</sup></bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>intronic</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>
                        <italic toggle="yes">CACNA1C</italic>
                      </bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>rs141391468</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>12:2470148</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>G/A</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.019</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>1.17</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.77, 1.57</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>3.59 × 10<sup>−8</sup></bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>intronic</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>
                        <italic toggle="yes">CACNA1C</italic>
                      </bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>rs7905470</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>10:7247513</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>A/C</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.199</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>−0.44</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>−0.59, −0.29</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>4.72 × 10<sup>−8</sup></bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>intronic</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>
                        <italic toggle="yes">SFMBT2</italic>
                      </bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs80214621</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5:157232090</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T/G</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.017</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.40</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.91, 1.89</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.14 × 10<sup>−8</sup></td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">intronic</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic toggle="yes">ITK</italic>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p><sup>1</sup> Abbreviations: rsID—reference snp cluster id; CHR—chromosome number; BP—base position from hg38 build; A1—effect allele; A2—allele 2; EAF—effect allele frequency; CI—confidence interval. <sup>2</sup> Associations are presented as standardized coefficients from additive genetic linear models. <sup>3</sup> Genome-wide significance <italic toggle="yes">p</italic> &lt; 5.00 × 10<sup>−8</sup> (<bold>bold</bold>).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
